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3A mis queridos Sr K y Óscar, por enseñarme la importancia de medir lo intangible.
To those who suffer, no matter do they meet criteria and for what diagnosis.
In the end it is sorrow what we work for, not the labels.
4Abstract
Depression is a common and disabling mental disorder. Empirical studies have shown that depressive 
symptoms vary substantially according to antecedents and outcome variables. Nevertheless, research is 
most often reduced to symptom counts and clinical settings. One of the limitations is the lack of 
knowledge about the presentation of individual symptoms and their association with clinically relevant 
outcomes, such as severe functional impairment. The heterogeneity of the symptoms may be an important 
source of information for a better understanding of depression. This thesis aims to produce empirical 
insights on how individual depressive symptoms relate to severe functional impairment in community-
based samples.  
In this doctoral dissertation, we used symptom-level data from two large epidemiologic studies 
that are representative of the population of the United States: the Collaborative Psychiatric Epidemiology 
Surveys (CPES), and the National Health and Nutrition Examination Survey (NHANES). Our results 
suggest that, in terms of statistical fit, sum-scores functioned almost as efficiently as symptom-level 
modeling in predicting self-rated functional impairment. However, examining symptoms individually 
offered a more detailed understanding of depression as a syndrome. For instance, symptom-level analyses 
revealed that age group moderated the associations of three symptoms with severe impairment. 
According to our results, middle-aged adults were more prone to feel severely impaired by these 
symptoms, as compared to adults aged 30 and below and in retirement age. The symptoms were 
depressed mood, self-criticism, and impaired concentration. Additionally, some symptoms did not have 
a significant association with high functional impairment in a fully adjusted model. This suggests that 
the association with impairment runs through other symptoms. In general, we found that cognitive-
affective symptoms of depression related consistently to severe functional impairment. Among them, 
self-criticism emerged as particularly informative for its consistent association with high functional 
impairment across analyses, and for its effect on other symptoms as revealed by cross-sectional direction 
of dependence analyses. A practical implication of this is that supporting individuals’ self-worth may 
protect against the development of depressive symptomatology and its corresponding impact on 
functioning.
Our findings motivate considering a wider range of symptoms, both in terms of severity and
content, for further understanding the heterogeneity of depression. Similarly, functional impairment as a 
core component of severity calls for systematic exploration, and for a more refined measurement. A
5better characterization of the severity of depression as a continuum is fundamental for theoretical 
developments in psychopathology, and potentially useful for planning more efficient interventions 
targeting the most disabling, dominant symptoms.
6Tiivistelmä
Masennus on yleinen, toimintakykyä vakavasti rajoittava sairaus. Aikaisemmassa tutkimuksessa 
masennusta ja sen vaikeusastetta on tarkasteltu pääasiassa masennusoireiden yhteenlasketun lukumäärän 
mukaan. Rajoituksena tässä lähestymistavassa on se, että siinä sivuutetaan yksittäisten oireiden 
esiintyminen sekä yksittäisten oireiden ja masennuksen vaikeusasteen yhteys. Aikaisemman tutkimuksen 
perusteella kuitenkin tiedetään, että masennusoireiden riskitekijät ovat erilaisia ja masennusoireet 
ennustavat erilaisia lopputulemia. Onkin mahdollista, että tämän oiretasoisen variaation ymmärtäminen 
on avainasemassa masennuksen ymmärtämisessä.
Tässä väitöstutkimuksessa tarkasteltiin yksittäisten masennusoireiden ja vakavan toimintakyvyn 
menetyksen yhteyttä väestötasolla. Tutkimuksen aineisto koostui kahdesta laajasta yhdysvaltalaisesta 
väestötutkimuksesta. Tutkimuksen tulosten mukaan masennusoireiden lukumäärä ennusti vakavaa 
toimintakyvyn menetystä lähes yhtä hyvin kuin yksittäiset masennusoireet. Yksittäisten 
masennusoireiden tarkastelu paljasti, että varsinkin kognitiiviset ja affektiiviset masennusoireet olivat 
johdonmukaisesti yhteydessä heikkoon toimintakykyyn. Lisäksi, keski-ikäisillä masentunut mieliala, 
itsekriittisyys ja keskittymisvaikeudet olivat yhteydessä toimintakyvyn menetykseen voimakkaammin, 
verrattuna nuoriin tai iäkkäisiin. Näistä oireista itsekriittisyys nousi tutkimuksen tuloksissa 
merkittävimpään asemaan, sillä se oli selkeästi yhteydessä paitsi toimintakykyyn, myös muihin 
masennusoireisiin. Myötätuntoisen asennoitumisen kehittäminen itseä kohtaan saattaa siten suojata 
masennuksen kehittymiseltä ja masennukseen liittyvältä toimintakyvyn heikkenemiseltä.
Tutkimuksen tuloksia voidaan hyödyntää esimerkiksi masennuksen mallien ja hoidon
kehittämisessä. Huomion kohdentamisesta keskeisimpiin masennusoireisiin voi olla hyötyä 
masennuksen hoitamisessa.
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Introduction
Depression and its attributed burden
Depression is a disabling mental disorder. According to the World Health Organization (WHO),
depressive disorders are responsible of an enormous amount of years of “healthy” life lost to disability 
For example, the last report of WHO attributed to depressive disorders the 5.8% of the overall of years 
lived with disability in the global population. The estimate was a sum of 44,175,000 years in 2016 across 
continents (WHO, 2018). Moreover, the WHO estimates that depressive disorders will rank first leading 
cause of loss of health by 2030 (WHO, 2004). Depression is not only disabling, but also common. More 
than 320 million of people live with depression, making it one of the most prevalent mental disorders 
globally (WHO, 2017). The estimated number of people suffering from depression increased by 18.4% 
between 2005 and 2015, presumably as a result of overall population growth and the proportionate 
increase in the age groups at which depression is more prevalent (Disease and Injury Incidence and 
Prevalence Collaborators, 2016).
It is very common for depression to overlap with a variety of other mental and physical illness, 
making it challenging to estimate its attributable overall burden (Alonso et al., 2011). Its association with 
mortality is indirect through comorbid diseases, but also independent (Cuijpers et al., 2014). At its worst, 
depression can lead to suicide. Persons suffering from depression are 20 times more likely to die to 
suicide than those not depressed (Ferrari et al., 2013). The WHO reports that, for every person who 
completes suicide, 20 or more may attempt to end their life (WHO, 2018). Similarly, an overwhelming 
majority of the patients diagnosed with an affective disorder report some kind of suicidal symptoms, 
from thoughts to repeated suicide attempts – some studies estimate that more than seven in ten (e.g. 
Aaltonen et al., 2016; Isometsä, 2014).
Thus, depression poses a substantial public health challenge with social, economic, and clinical 
implications. Psychotherapy appears to have only moderate effect, and seems to be equal beneficial 
across severity levels and types of intervention (Barth et al., 2013; Cuijpers, 2019). In what comes to 
pharmacotherapy, the effect size of antidepressant efficacy in trials is similarly modest, with little 
improvement over placebo (Cipriani et al., 2018; Khan & Brown, 2015; Khan, Faucett, Lichtenberg, 
Kirsch, & Brown, 2012). The effects of antidepressants are generally seen for the most severe cases of 
depression, and some experts argue that most of the patients with the disorder do not receive a clinically 
significant benefit out of medication (Fournier et al., 2010; Khan, Leventhal, Khan, & Brown, 2002; 
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Kirsch, 2014; Kirsch et al., 2008). Furthermore, the efficacy of clinical trials is not always generalizable 
to the clinical practice, since it has been shown that the majority of patients do not receive the same level 
of clinical attention than the participants in efficacy trials, and samples are not representative due 
exclusion criteria (Lorenzo Lorenzo-Luaces, Zimmerman, & Cuijpers, 2018; Sugarman, 2016). A recent 
meta-analysis on the efficacy of app-supported smartphone interventions found that these outperformed 
significantly control conditions in improving depressive symptoms (Linardon, Cuijpers, Carlbring, 
Messer, & Fuller-Tyszkiewicz, 2019), which suggests that some treatment gaps of depression could be 
reduced by remote interventions. The efficacy of smartphone interventions, however, does not seem to 
outperform that of active psychological interventions. 
This problematic situation motivates a closer look at whether the diagnostic definition, Major 
Depression (MD1), accurately reflects the underlying depressive syndrome. Depression, as other mental 
disorders, is diagnosed based on a standard set of criteria that can be found in manuals or classification 
systems. Two classification systems dominate mental health diagnostics: the International
Classification of Diseases (ICD), published by the World Health Organization (WHO, current version 
ICD-10), and the Diagnostic and Statistical Manual of Mental Disorders (DSM), which is produced by 
the American Psychiatric Association (APA, current version DSM-5). Depression, historically 
documented as melancholia, is an old malady that has been well described for centuries. The modern 
operational definition2 of depression as a disorder has remained mostly unchanged since Feighner et al.
proposed their diagnostic criteria in 1972, which included depression within the section of Primary 
Affective Disorders. Nowadays, it is found in the diagnostic manuals as Major Depression Disorder
(MDD). In this dissertation we will generally refer to depression as a syndrome, varying from mild 
                                                
1 Major Depression is coded in the diagnostic systems as both Episode (MDE) and Disorder (MDD). For endorsing a MDD, 
the individual must have previously met criteria for MDE. The main difference between Episode and Disorder is duration: a 
two-week period is considered as an Episode, while a Disorder requires repeated episodes. The symptoms included and 
most of the other diagnostic criteria remain the same, and thus the description and further discussion of the symptom criteria
in this dissertation involves MDE and MDD. This is the general case in psychiatric literature as well. In this dissertation, we 
will use the abbreviation MD to refer to clinical depression (both MDE and MDD). 
2 The term “operational definition” was coined by Percy W. Bridgman as a set of operations and assumptions stablished to 
define concepts which are not directly measurable. For example, length has no natural unit. Instead, it depends on the 
operational unit chosen, which may be inches or centimeters, and a set of assumptions. It occurs similarly with 
psychological concepts or constructs, such as intelligence or depression. An operational definition stablishes a common set 
of criteria to measure an intuitive concept. In their discussion about the consequences of the operationalism in Psychiatry, 
Parnas and Bovet (2014) argued that “Defining concepts by operations appeared to facilitate implementation of the 
verifiability criterion of meaning. It also seemed to solve the problem of potential theory-, habit-, or language-derived 
contaminations of scientific, observational statements about the world” (p. 192). 
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representations (e.g. subthreshold3) up to the clinical disorder. The term Major Depression (abbreviated 
as MD, and the corresponding specifiers of Episode and Disorder, MDE and MDD) will be used when 
referring specifically to clinical depression.
Both diagnostic systems in use, ICD and DSM, largely resemble each other in the 
operationalization of depression. In both, the symptoms considered diagnostic criteria4 for an episode of 
MD are depressed mood, loss of interest or pleasure, decreased energy, feelings of guilt or worthlessness,
disturbed sleep, changes in appetite or weight, poor concentration or indecision, psychomotor alterations,
and death thoughts that may at their worst lead to planning and committing suicide. The episode should 
last at least two weeks and be discarded other causes to it (such as being under the effect of drugs or 
another mental disorder). The symptoms must cause substantial impairment in daily functioning, such as 
daily life activities, social participation, and self-care. The reader can find in Table 1 the operational
definition of MDE according to DSM-IV. This definition covers the same symptoms included in the last 
edition, and is the one presented here for being used by the epidemiological datasets included in the 
original articles belonging to this dissertation. The changes introduced in DSM-5 relate to specifiers and 
exclusion criteria of MD, having a potential repercussion on prevalence rates of the disorder and its 
profiling. However, the aspects of depression examined here are not affected by the changes from the 
fourth to the fifth edition of DSM. 
The diagnostic definition of MD, according to ICD-10, has the following differences with respect 
to that of DSM: (1) increased fatigability is a core symptom, and the requirement is endorsing at least 
two of these three core symptoms – to which anhedonia and depressed mood belong. Also two other 
symptomatic criteria are included: (2) reduced self-esteem and self-confidence, and (3) bleak or 
pessimistic views of the future. These two criteria are line with the cognitive perspectives on depression. 
(4) Only loss of appetite and weight are considered, not increased appetite or weight. While the symptom 
threshold of DSM-IV and DSM-5 was set at 5 five symptoms (including one core symptom), ICD-10
                                                
3 Subthreshold depression refers to those symptom presentations that do not meet the diagnostic criteria but are, to some 
extent, clinically relevant. The person may endorse a number of associated symptoms but not the two-week duration 
criterion, or vice versa.
4 The term diagnostic criteria refers actually to all criteria defining a given diagnosis, usually denominated with the Roman 
alphabet in the diagnostic systems (e.g. A, B, C… see Table 1). In psychiatric literature, the term diagnostic criteria most 
often refers to the associated symptoms contained, for example, in the criterion A of Major Depression (i.e. referred to with
numbers and between parenthesis, see Table 1). We will use here the term “symptom criteria” to refer to them, and 
“diagnostic criteria” to refer to the whole set of criteria composing a diagnostic definition. We acknowledge focusing on 
symptom criteria is a simplification of the diagnostic definition. 
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requires four symptoms of which at least two must be core symptoms, and two or more associated 
symptoms. In ICD-10 it is defined a specific depressive syndrome called “somatic”, which is described 
based on a certain presentation of the aforementioned symptoms plus marked loss of libido (WHO, 2004, 
p. 100). Psychotic features are described in both ICD-10 and DSM editions.
In the next sections of the Introduction we will present some challenges to the current 
diagnostic system of depression. The connecting thread for these challenges is the heterogeneity of 
symptom presentations contained within the diagnostic label of “depressed”. We will first describe
some implications, strengths, and pitfalls of treating depression as an aggregate5. Then, we will present 
some empirical evidence of heterogeneity across individual depressive symptoms. Last, we will 
consider several methodological foundations of this doctoral dissertation. These methodological 
aspects set the ground for better understanding what psychological measurement entails concerning our
work. 
Views on depression: on and off?
The statistics of depression are generally based on cases which are diagnosable with MD. A consequence 
of classifying persons between the conditions of ill and healthy (e.g. MD present or absent) is that all 
those labelled as healthy are considered as equally healthy, and likewise all those ill are analogously ill. 
Such assumption treats within-category cases as homogeneous (i.e. undifferentiated). Mental health 
professionals have questioned this simplification with the following argument: are all the cases diagnosed 
with clinical depression qualitatively the same? If so, are also those cases under the clinical threshold of 
MD equally healthy? To simplify, can we assume that MD turns on and off depending on whether a 
person meets the diagnostic criteria? 
Researchers were skeptical of this perspective and argued that, instead of being a distinct and 
discrete category, depression expands along a continuum (or gradient) of severity, and that the 
threshold for “clinical caseness” (i.e. MDE or MDD) is an artificial split to this continuum. According 
to this perspective most of the population, who shows none or quite few depressive symptoms, would
                                                
5 An aggregate can be defined as “a mass or body of units or parts somewhat loosely associated with one another”, and also 
as “the whole sum or amount” (Merriam-Webster dictionary, 2019). These acceptations describe well what the diagnostic 
label of depression means in the context of this dissertation. 
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Table 1. Diagnostic criteria for Major Depressive Episode in DSM-IV
A. Five (or more) of the following symptoms have been present during the same 2-week period and 
represent a change from previous functioning; at least one of the symptoms is either (1) depressed
mood or (2) loss of interest or pleasure.
(1) Depressed mood most of the day, nearly every day, as indicated by either subjective 
report (e.g., feels sad or empty) or observation made by others (e.g., appears tearful). Note: In 
children and adolescents, can be irritable mood. 
(2) Markedly diminished interest or pleasure in all, or almost all, activities most of the day, 
nearly every day (as indicated by either subjective account or observation made by others).
(3) Significant weight loss when not dieting or weight gain (e.g., a change of more than 5% 
of body weight in a month), or decrease or increase in appetite nearly every day. Note: In 
children, consider failure to make expected weight gains.
(4) Insomnia or hypersomnia nearly every day.
(5) Psychomotor agitation or retardation nearly every day (observable by others, not merely 
subjective feelings of restlessness or being slowed down).
(6) Fatigue or loss of energy nearly every day.
(7) Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or guilt about being sick).
(8) Diminished ability to think or concentrate, or indecisiveness, nearly every day (either by 
subjective account or as observed by others).
(9) Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a 
specific plan, or a suicide attempt or a specific plan for committing suicide.
B. The symptoms cause clinically significant distress or impairment in social, occupational, or other 
important areas of functioning.
C. The episode is not attributable to the physiological effects of a substance or to another medical 
condition.
D. The occurrence of the major depressive episode is not better explained by schizoaffective 
disorder, schizophrenia, schizophreniform disorder, delusional disorder, or other specified and 
unspecified schizophrenia spectrum and psychotic disorders.
E. There has never been a manic episode or a hypomanic episode.
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belong to the low side of the continuum. The opposite extreme represents those suffering from very 
severe depression, and expectedly diagnosed with MD. This hypothesis is referred to as dimensional, as
compared to the view of depression being a categorical trait (i.e. a “taxon”). The categorical view 
entails that depression can be easily differentiable between those who “have it” and those who do not. 
The taxon of depression, then, would have a boundary that naturally splits the population into groups.
Despite some evidence in favor of MD as a taxon (Ruscio, Brown, & Ruscio, 2009; Ruscio, 
Zimmerman, McGlinchey, Chelminski, & Young, 2007), researchers came to agree that, like most of 
psychopathology, depression is best modeled as a dimensional continuum (Haslam, Holland, & 
Kuppens, 2012; Plomin, Haworth, & Davis, 2009; Ruscio, 2002; Ruscio et al., 2007).
Despite of a stable consensus on the dimensional nature of depression, classification based on 
categories is in extensive use. Both in clinical practice and research, professionals use categories for
distinguishing depressed from non-depressed individuals. In clinical and applied contexts there are 
compelling reasons for it: the diagnostic classifications supply labels to ease communication among 
professionals, refer patients to treatment programs, assist training, facilitate forensic issues, and a long 
etcetera (Frances, 2016). Indeed, the epidemiological numbers about prevalence and burden of disease 
we provided in the previous section are possible due to classifying. In research, a common practice is 
dividing participants into depressed and non-depressed by using the cut-off score from depression 
inventories. This allows straightforward comparisons between groups and looking into, for instance, 
predictors or outcomes associated distinctively with the depressed group. 
Issues concerning aggregated approaches in depression research
There are different ways to handle depression scores in research, apart from the aforementioned binary 
classification (i.e. MD yes/no). In this section, we will introduce in more detail the characteristics of 
aggregates in mental health, and elaborate on three of the main challenges posed by depression 
aggregates.  
Grading depressive symptoms according to severity has become a standard. Some influential 
works in the late 90’s found a monotonic increment (i.e. dose-response association) in validators of 
pathology as the number of depressive symptoms increased (Kendler & Gardner, 1998; Kessler, Zhao, 
Blazer, & Swartz, 1997). This means that, the more symptoms, the more severe were other correlating 
variables, such as risk of future depressive episodes, average length of longest episode, or impairment.
These findings are compatible with the consensus on the dimensional nature of psychiatric traits, and 
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posited the intuitive rule that the more symptoms (most often the nine symptom criteria), the more severe 
the disorder. It is fairly intuitive that the more difficulties a person experiences, the more vulnerable they 
are and higher their risk of poor functioning. Thus, using sum-scores or symptom counts as aggregates 
of depression severity seemed a reasonable heuristic, which quickly took over the field.
A pragmatic compromise between binary classification and continuous sum-scores is ordinal 
grading (Kraemer, 2007). It consists on matching scores according to a severity arrangement, as for 
example “mild”, “moderate”, and “severe”. This is the approach currently implemented in the DSM-5
for severity specification of MD, whom rating increases from mild to severe, depending on the number 
of symptom criteria and other indicators (APA, 2013). These categories can have practical consequences, 
such as recommending a specific treatment for a person according to the severity of their depressive 
scores (APA, 2010). The extended habit of using aggregated measures of depression as a proxy for 
disorder severity, was it ordinal grading or sum-scores, is backed by the literature showing that severity 
validators increase monotonically together with aggregated scores. Moreover, aggregates are extremely 
efficient variables for being easy to calculate, and for the wealth of information they contain in only one 
value. However, they also come with some caveats.
The first issue relates to the breadth of depressive measurement and its methodological 
implications. Depressive symptoms are an inevitable source of heterogeneity. Old characterizations of 
depression include affective, motivational, cognitive, and neurovegetative symptoms as diverse as 
derealization, constipation, headaches, crying spells or wretchedness (Kendler, 2016). The symptom
criteria of today’s DSM and ICD are much more concessive, but still include symptoms very different in 
nature (i.e. affective-motivational, cognitive, and somatic; see Table 1). The most popular inventories 
used to measure depression in research include sundry checklists of symptoms, each assessing depression 
based on their own description. Fried (2017) conducted a content analysis of seven commonly used 
depression scales. He identified 52 different symptoms, of which only 12% appeared in all scales.
Santor and colleagues (2006) examined the depression scales published in the previous 80 years. 
They concluded that scales vary importantly not only regarding content, but regarding the proportion of 
items allocated to assessing a given symptom domain (e.g. cognitive, somatic), and concerning item 
format. For example, some scales measure frequency of symptoms, while others query about intensity. 
In general, the choice of response format when designing rating scales has received little attention in 
research, and the reasons for choosing a given response format are rarely documented (Zimmerman, 
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Morgan, & Stanton, 2018). So far, there is not much evidence on which response format is more valid to 
measure depressive symptoms: frequency, recurrence, intensity? Regardless of the poor overlap in terms 
of content and format between scales, the standard is considering them all as measurements of depression,
with no distinction. Aggregated depression measures are insensitive to all discrepancy: participants are 
simply given a value (e.g. “depressed”, “moderate”, or a score of 12), reducing the variegated symptoms 
to a single piece of information.
A second implication of the aggregated approach in depression research stems from the 
variability in symptom presentations. Depressive syndromes vary to such an extent, that it has been 
stated that “to declare that all those satisfying the DSM criteria for the diagnosis of major depression are 
suffering from the same disorder seems like magical thinking” (Goldberg, 2011). Research suggests that 
there is no such thing as “diagnostic prototype” in MD, with only a small amount of frequent 
combinations, that account for less than half of the patients diagnosed (Zimmerman, Ellison, Young, 
Chelminski, & Dalrymple, 2015). In a study of 3703 patients, the most common symptom profile was 
endorsed by less than a 2% (Fried & Nesse, 2015a). The variability existing within the label of 
“depressed” is so large, that some experts have attributed to it the low success of antidepressants (Khan, 
Mar, & Brown, 2018; Østergaard, Jensen, & Bech, 2011). According to them, it is possible that the 
etiology of the clinical syndrome does not correspond to the classification of MD.
Subtyping individuals with MD into more homogeneous categories (e.g. endogenous vs 
exogenous, or dominance of melancholic, psychotic, or manic features, etc.) has been tried and 
extensively considered (Parker, 2018). Some of these subtypes were present in DSM-IV. However, 
empirical studies in profiling of depression have not yielded conclusive evidence (Arnow et al., 2015; 
Harald & Gordon, 2012; van Loo et al., 2012). Recent research has revealed an additional source of 
heterogeneity: it seems that the structure of depression differs between general and depressed 
populations, and also between clinical subpopulations (Foster & Mohler-Kuo, 2018; Wanders et al., 
2015). This means that the way depressive symptoms manifest in the case of pathologically depressed 
individuals may be different from in the general population, and even vary across depressed 
subpopulations according to variables such as the degree of chronicity, or comorbid anxiety. An example 
of this different presentation could be, for instance, that some symptoms are not just more prevalent in 
clinical compared to community samples, but have different co-occurrence patterns. Dividing 
participants into subsamples according to cut-offs on the sum-scores is similarly problematic (Muthén, 
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1989). To summarize, the inconsiderate use of aggregates seems open to doubt from a methodological 
standpoint.
A third aspect concerning the use of aggregates is the boundary drawn between “depressed” and
“not depressed. This is an overarching challenge for mental disorders: there is no natural border 
separating illness from health (e.g. Kendell & Jablensky, 2003). In depression, there are no biological 
grounds for this diagnosis, and distinguishing between normal and pathologic levels of sadness is blurry 
and very complex. In these days, the threshold to classify cases and non-cases of MD in the diagnostic 
manuals is arbitrary. Arbitrary means there were no empirical grounds for setting them. A notable 
example is that the Feighner criteria relied strongly on a particular article by Cassidy and colleagues 
(1957). In this article, the authors used a threshold of six out of ten symptoms to diagnose clinical 
depression because “it sounded about right” (Kendler, Muñoz, & Murphy, 2010, p. 136). The DSM 
requirement has traditionally been to endorse five out of nine symptom criteria, with the condition of one
of them being depressed mood or anhedonia. However, stablishing a threshold for MD has very important 
implications, especially because the number of symptoms is an indicator of severity of the disorder 
according to DSM-5. For example, a person not meeting the five symptom criteria in the last two weeks 
will have no access to public healthcare treatment nor be covered by their insurance in some countries.
This decision is controversial: there is evidence that some cases of subthreshold depression show as high 
or higher impairment than diagnosable cases (Wakefield & Schmitz, 2017; Wanders et al., 2016; 
Zimmerman et al., 2008).
The threshold for MD is a delicate issue with broad implications. One of the reasons why experts 
have not reached a conclusion about when does depression become a disorder is ideological, namely the 
dilemma between the hazardousness of false positives and false negatives. Put differently, there is a
moral choice in pathologizing intense but normal suffering, against leaving undiagnosed vulnerable 
individuals. This is naturally a source of deep disagreement (Frances, 2013; Horwitz & Wakefield, 2007; 
Kessler et al., 2003; Maj, 2014). Moreover, the empirical evidence is mixed. For example, a meta-
analysis study showed that the increased risk of mortality in subclinical MD is as high as for clinical MD
(Cuijpers & Smit, 2002). At the same time, it has been found that the milder cases of MDD do not respond 
to antidepressant medication better than to placebo (Khan, Brodhead, Kolts, & Brown, 2005). When 
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Mario Maj6 posed the still timely question when does depression become a mental disorder? (2011), he 
concluded that “the threshold for a depressive state deserving clinical attention may be lower than that 
fixed by the DSM-IV, but the threshold for a depressive state requiring pharmacological treatment is 
likely to be higher. These thresholds may need to be based on the overall severity of depressive symptoms 
rather than, or in addition to, their number” (p. 86). 
The cut-offs for severity labels are similarly problematic: what is the difference between “mild” 
and “moderate” depression? Research studying the degree of overlap between severity levels of different 
depression questionnaires have found that these differ substantially. This implies, for instance, that a
person may receive the grading of severe depression according to a given scale, and moderate according 
to another. Moreover, there is no gold standard to judge whether it is the first scale which over-classifies, 
or the second that under-classifies (Zimmerman, Morgan, et al., 2018).
To sum up, demarcating what is or what is not clinical depression is an extremely challenging 
enterprise in research, especially for community-based, broad epidemiological studies in which limited 
resources and wide goals restrict the depth of the information collected. Aggregated measures of 
depression, such as labels or sum-scores, do not assist in easing the problem because they are rather 
opaque, and values are highly variable across instruments for the reasons elaborated above. Apart from 
those sources of variability, the symptoms themselves vary according to different factors. In the next 
section we will briefly review empirical evidence of the heterogeneity found across depressive 
symptoms.
Heterogeneity among depressive symptoms
In the previous section, we reflected on research approaches based on aggregated measures of depression.
On one hand, they are informative and efficient ways to handle very complex information. On the other 
hand, there are a number of less desirable consequences. We reviewed some of them: the heterogeneity 
in measurement tools of depression, heterogeneity in symptom occurrence, and lack of golden standard 
to split depressive scores into categories.
                                                
6 Mario Maj is an Italian psychiatrist and professor who was President of the World Psychiatric Association between 2008 
and 2011, and of the European Psychiatric Association in 2003 and 2004. He is the founder and Editor of the journal World 
Psychiatry.
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A common aspect of aggregated scores that makes them conceptually problematic is the implicit 
assumption that all depressive symptoms are interchangeable. Routinely, the symptoms added to the 
count weight the same (i.e. just “one symptom more”). Thereby it is common to symptom counts and 
labels in depression is that two persons with the same number of symptoms may have totally different 
symptom combinations – with all their potential consequences – which goes unnoticed by aggregating 
them (Fried & Nesse, 2015a; Østergaard et al., 2011). From the perspective of psychometrics this does 
not seem justified, since depression scales, apart from differing from each other in content and response 
format, tend to be multidimensional and/or not invariant across samples (e.g. Fried et al., 2016).
Subscales from the same questionnaire may also show low intercorrelations (Jang, Livesley, Taylor, 
Stein, & Moon, 2004). Under these circumstances, compiling multidimensional information into a single 
aggregate as de facto routine seems questionable. In the next paragraphs we will present empirical 
evidence on how individual symptoms associate differently with antecedent and outcome variables. 
Antecedents 
Research investigating the association of individual symptoms with risk factors and antecedents has 
shown that particular adverse events may trigger different symptoms of depression. Among the adverse 
events studied are stress, failure, romantic loss, or social conflict. For example, appetite decrease is
typically present in response to social loss (Cramer, Borsboom, Aggen, & Kendler, 2012; Keller, Neale, 
& Kendler, 2007). Moreover, there seems to be congruence to some extent between the adverse situation 
suffered and the functionality of the symptoms. Keller and Nesse (2006) studied that guilt, rumination, 
fatigue, and pessimism were prominent following failed efforts; while crying, sadness, and desire for 
social support were prominent following social losses. Depressive symptoms also differ in remote 
antecedents, like childhood stress or abuse, and parental coldness: anhedonia, weight loss, and trouble 
sleeping were linked to these environmental risk factors, but not to heritable factors.
Fried and colleagues (2014) found that other variables associated with individual symptoms are 
neuroticism (to self-blame and the core symptoms), sex (suicidal thoughts to being male), or work hours
(to fatigue particularly). Oquendo and colleagues (2004) discovered that symptom occurrence patterns 
were instable in a clinical sample of recurrent MDD followed for 24 months, suggesting that individual 
symptom variability is more subject to contextual factors than to individual styles. This is an interesting 
piece of information, given that aggregate scores of depressive symptoms tend to be rather stable across 
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time (Struijs et al., 2020; Verduijn et al., 2017; Verhoeven, Wardenaar, Ruhé, Conradi, & de Jonge, 
2018).
Few studies have identified specific neurobiological and metabolic correlates with individual 
depressive symptoms, revealing that symptoms also associate with some remote and proximal 
biomarkers apart from contextual factors (Jang et al., 2004; Jokela, Virtanen, Batty, & Kivimäki, 2016; 
Lamers, Milaneschi, de Jonge, Giltay, & Penninx, 2018; Lux & Kendler, 2010; Myung et al., 2012). In 
general, it seems that somatic symptoms are more heritable and consistently related to biomarkers than 
cognitive and affective symptoms. 
Outcomes 
Studies also show that depressive symptoms are heterogeneous in terms of outcomes. Outcomes are 
particularly interesting because they are indicators of the impact of a symptomatic presentation.
Compared to identifying risk factors, it may be more cost-effective to identify which are the symptoms 
or combinations related to more severe impact on well-being. For instance, it seems that risk factors can 
predict the onset of different symptoms, but do not predict prognosis (Eaton et al., 2008; Hardeveld, 
Spijker, De Graaf, Nolen, & Beekman, 2010). Outcomes, in turn, may be more closely related to the
prognosis of the disorder.
Functional impairment is one of the central outcomes of depression. Poor functioning associated 
with health can be assessed in different life domains, from personal relationships and work performance 
to autonomy to carry out self-care and daily activities. Impairment extends throughout the whole range 
of depression in varying intensity, ranging from no impairment to severe disability. It is also a standard 
in measuring clinical features like severity of the syndrome, quality of the remission of an episode, and 
global attributed burden. The branch of research devoted to study MD remission has traditionally 
examined how concrete symptoms relate to functional impairment. Remission studies research whether 
specific treatment options have a role in recovery from depression, such as the efficacy of concrete drugs 
or psychotherapy. However, there are several reasons for caution in generalizing their findings.
First and differently from observational studies examining symptom distribution in a given 
population, treatment efficacy studies examine cases after enrolling to a certain antidepressant or 
psychotherapy treatment, and thus exclude all those cases of depression who do not access any treatment 
– it has been estimated that a 56% of diagnosable MD do not seek for help (e.g. Kohn, Saxena, Levav, 
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& Saraceno, 2004). Second, results from efficacy trials may differ from those of the general population
because of eligibility criteria. Efficacy trials have so stringent inclusion requirements that their samples 
differ substantially from the population seen in common clinical practice. A study estimated that only 
17-25% of out-patients suffering from MDD would be eligible for antidepressant efficacy trials (van der 
Lem, van der Wee, van Veen, & Zitman, 2011). A recent study examining placebo-controlled studies 
across 20 years has estimated that the exclusion rate was over 76%, and varied across medications up to 
99% (Zimmerman, Balling, Chelminski, & Dalrymple, 2020). Common reasons for exclusion are 
symptom severity, presence of other disorders, and suicidality (Zimmerman, Clark, et al., 2016b, 2016a; 
Zimmerman, Mattia, & Posternak, 2002; Zimmerman, Multach, et al., 2016).
Moreover, the results from clinical trials are not directly comparable among themselves for 
several reasons. First, there have been observed systematic differences in the sampling: psychotherapy 
studies include other comorbidities more often than antidepressant studies, and antidepressant trials 
include more severe and prolonged cases of MDD (Lorenzo-Luaces, Zimmerman, & Cuijpers, 2018). It 
also appears that depressive symptoms differ in their response to treatment (de Vries et al., 2018; Fournier 
et al., 2013; Olbert, Rasmussen, Gala, & Tupler, 2016; Taylor, Walters, Vittengl, Krebaum, & Jarrett, 
2010). Some studies have also pointed to the side effects of antidepressants: symptoms like sleep 
disturbance, concentration problems and fatigue, anxiety, sexual dysfunction, and even suicidal ideation 
are among possible consequences of antidepressants, and thus particular symptoms may be reduced while 
others increased by a drug (Fried & Nesse, 2015b). Because of these reasons, there are no grounds to 
extrapolate the findings on impairment from clinical trials to the wider, general population.
Despite its far-reaching consequences, the impairment related to individual depressive symptoms 
has been described systematically by only few studies. Tweed (1993) interviewed 2687 individuals about 
concurrent and lingering social impairment as a consequence of individual symptoms. He found six 
symptoms which explained impairment: depressed mood, durable dysphoria, cognitive difficulties
(concentration and slow thinking), suicidal ideation, fatigue, and lack of sexual interest. In another study, 
Faravelli et al. (1996) reported an association between number of symptoms and their severity. However, 
the qualitative categorizations the authors made (e.g., melancholic, somatic, etc.) usually attained better 
discrimination than the number of symptoms in explaining functional impairment: the clusters including 
cognitive-affective and psychosocial symptoms of depression were stronger indicators of impairment
than the somatic symptoms (with exception of motor retardation).
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In a more recent study, Fried and Nesse (2014) looked into the independent associations of
depressive symptoms with several functioning domains in a clinical sample of MDD. The participants 
were queried about symptoms and functional impairment within the first week of antidepressant intake.
They found that sad mood and concentration problems were the symptoms most strongly related to
impairment across all domains. Anhedonia, retardation, fatigue, guilt, and suicidal ideation followed 
next. Tweed’s study was based on a community sample, Faravelli and colleagues used a sample of 
patients referred to them for day-hospital treatment, and Fried and Nesse used data from the STAR*D 
study, a randomized clinical trial in which participants received citalopram. There are few studies so far 
in addressing directly the connection of impairment with individual symptoms of depression (at the 
symptom level and not through classes or clusters). Their results seem difficult to compare due to diverse 
sampling, choice of symptoms assessed, and conceptualization of impairment.
Suicidal behavior is another important outcome of depression. Perceived burdensomeness, 
hopelessness and loneliness have been traditionally linked to enhanced risk of attempting suicide (e.g. 
Van Orden, Lynam, Hollar, & Joiner, 2006), and among the somatic symptoms insomnia has been found 
to predict suicide attempt independently of the diagnosis of depression (Lin et al., 2018; Pigeon, Pinquart, 
& Conner, 2012). Most of the studies, however, study depression as an aggregate and thus do not adjust 
for other symptoms individually. In a population-based study adjusting for all symptoms simultaneously, 
Bolton et al. (2010) found that only the symptoms of anhedonia, worthlessness, and guilt, remained 
statistical significant predictors of suicidal attempt when controlling for all symptoms individually, 
symptom count, and comorbid psychiatric disorders together with sociodemographic predictors. In 
another epidemiological study they found that, among those with diagnosable MD, feelings of 
worthlessness was the symptom most strongly associated with history of suicide attempts (Bolton, Belik, 
Enns, Cox, & Sareen, 2008).
There is some emerging evidence of how individual depressive symptoms react to interventions, 
showing heterogeneity (Boschloo et al., 2019; van Eeden, van Hemert, Carlier, Penninx, & Giltay, 2019).
This is undoubtedly in strong connection to the topic of depression outcomes. However, the association 
between individual symptoms with outcomes of depression, like persistence or recurrence, in an 
epidemiological context, is different for not being dependent on receiving a specific treatment (i.e. a 
given type of psychotherapy or a specific medication, to which understandably some symptoms could be 
more reactive than others). Thereby, both topics answer to different questions. Symptoms reacting to 
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intervention positively do likely alleviate depression severity and could contribute to better prognosis,
but the question of which symptoms do predict relapse or chronicity themselves is different, and remains 
yet mostly unexplored.
A large proportion of individuals are at risk of developing depression at some point of their lives, 
but only half of those who reach clinical levels will fall into chronic and resistant forms (Lorenzo-Luaces, 
2015). Chronicity, recurrence, suicidality, and hospitalization are, indeed, well-recognized outcomes of 
depression. These are most often seen when the depressive syndrome is severe enough, while functional 
impairment may occur much earlier. Studies have found that functional impairment is itself a risk factor 
for recurrence of depressive episodes (Gilmer et al., 2005; Solomon et al., 2004). Moreover, in their
recent work examining functioning pre- and post-depressive episode, Bos et al. (2018) found evidence
suggesting that it is pre-existing functioning which predicts future depressive episodes, instead of 
residual symptoms causing impairment by lingering. This conclusion was based on literature review and 
their own empirical findings, which examined mental and physical functioning. Thus, identifying which 
symptoms are most often related to severe impairment can be a first step for detecting vulnerable cases
whose prognosis could be at risk of worsening. However, this is only a possibility given the incomplete 
scientific understanding of the associations among clinical outcomes of depression.
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Methodological foundations
Main psychometric approaches to modeling depression
Psychiatry, a branch of medicine, has traditionally studied psychopathology as any other medical disease. 
The medical model of disease stablishes that symptoms root from physical dysfunctions (e.g. impaired 
language and memory, labile affect, etc., as result of neurological and degenerative processes). The 
usefulness of a diagnosis relies on treatment decisions: given a set of symptoms stemming from an 
identified dysfunction, a suitable treatment can be chosen. Such framework implies, in psychopathology, 
that a mental disorder causes the symptoms we observe. So far, most mental disorders lack a clear 
neurobiological mechanism and react variably to different treatments (Kendler, 2012; Singh & Rose, 
2009), and MD is not an exception (Kennis et al., 2018). The difficulties with the medical model are not 
surprising in the case of psychiatric nosology7. This is because the current psychiatric classifications are 
the result of consensus among experts and were not built upon etiological evidence, nor have they 
undergone exhaustive empirical validation (Kendler & Parnas, 2012, 2014).
There is a wide research program aiming for better models of psychopathology. Among the main 
issues is the structure of psychopathology. Psychopathology models can target content-related questions
(e.g. what are the factors underlying comorbidity across disorders? Is legal problems a valid diagnostic 
criterion for substance-related disorders?), and structural issues (e.g. do psychiatric disorders explain 
symptoms, or result from their interactions?). The classic methodology to address these questions comes 
originally from the field of Psychology, and it is based on latent trait modeling. Latent traits are 
unobserved, unmeasured variables which are most often modelled mathematically through confirmatory 
factor analysis, latent classes or profiles, or Item Response Theory models (Borsboom et al., 2016).
Across these different methods, latent traits are used to model a common cause8 which explains the 
correlation among observed variables (e.g. feelings of worthlessness Å depression Æ insomnia). A 
common cause model has the important implication that two items (e.g. symptoms) of the same trait (e.g. 
disorder) are independent from each other conditional on the trait (e.g. Cov[feelings of worthlessness, 
                                                
7 Nosology is a branch of medical science that deals with the classification of diseases. Diseases may be classified according 
to their pathogenesis (biological mechanisms causing it) or to the symptoms, in which case the term “syndrome” is 
appropriate. In practice the words disorder, disease, and syndrome are used interchangeably. 
8 Latent variables are not exclusive of common cause models. A common cause model uses most often a latent variable or 
trait in order to explain the covariation among the observed variables. A latent variable is any unobserved variable which is
estimated within a model based on a group of indicators. For example, error terms in structural equation modeling are latent 
variables.   
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insomnia│depression]  = 0; e.g. Thoemmes, Rosseel, & Textor, 2018). These models embody the
reflective structure of psychopathology (i.e. the items reflect a latent trait). Such structure suits well the
dimensional understanding of psychopathology: the higher the position on the latent trait continuum, the 
more likely is the occurrence of symptoms. The reflective framework became rapidly popular and has 
dominated psychopathology, via latent trait modeling, for decades (Duncan-Jones, Grayson, & Moran, 
1986).
The interpretation of what a latent trait is in psychopathology remains an open question, and 
indeed a vastly discussed one. The latent trait framework estimates latent variables which explain the 
covariance in the data. Such latent framework is compatible with the medical perspective that mental 
disorders are biological-based phenotypes, by representing them as latent traits (Franić et al., 2013). The 
same framework is also suited to the viewpoint that latent traits reflect vulnerability or susceptibility to 
certain symptomatology (e.g. Caspi et al., 2014; Kotov, Krueger, & Watson, 2018). More recently, some 
authors have argued that a latent trait emerges when a set of random variables correlate positively with 
each other (van Bork, Epskamp, Rhemtulla, Borsboom, & van der Maas, 2017; Van Der Maas et al., 
2006), as often happens with items in a questionnaire measuring related symptoms. This would imply 
that many latent variables found in empirical research were actually a mathematical artifact. This
argument is at the core of a novel perspective on psychopathology, which has become increasingly 
popular in the last years under the name of network approach to psychopathology (Borsboom, 2017).
The network approach proposes a formative structure for mental disorders as opposed to the 
reflective structure characteristic of latent trait models. According to this theory, mental syndromes are 
constituted and maintained by networks of symptoms that affect each other. In MD, for instance, it could 
be that sleep problems cause fatigue and irritability the following day, which in turn dampens mood and 
affects performance, leading to frustration and self-reproach. The theory posits that individual differences 
in network structure and vulnerability affect symptom-to-symptom dynamics, which in turn lead to 
different symptom manifestations (e.g. some individuals suffer characteristically from somatic 
symptoms, while others have more cognitive symptoms). Therefore, the positive manifold results from
mutual, direct connections between symptoms (van Bork et al., 2017). This theory has become popular 
for its emphasis in the concrete mechanisms operating in psychopathology, which smoothly connect to 
intervention planning (Cramer et al., 2016). The network approach has generated plenty of discussion 
and a number of insightful findings. However, being this approach relatively recent and mostly limited 
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to cross-sectional settings, the knowledge generated is still preliminary. For some stimulating thoughts 
on psychometric modeling of psychopathology we refer the reader to Fried (2017), Reise & Rodriguez 
(2016), or Kotov, Krueger & Watson (2018).
Validity in psychiatric disorders
A psychological measure is considered valid when it measures what it claims to measure. Likewise, 
conclusions made out of a study are valid when being coherent with the empirical evidence, and its 
resultant interpretations justified. Thus, validity involves not only measurement instruments but all the
consequences that may follow measurement. In this section we will present some implications of validity 
for mental disorders.
Validity studies are abundant in psychometrics. One can examine the content validity of the
operationalization of a construct9, or how a rating scale measures such construct (e.g. what does the 
construct of intelligence involve? Is it covered in its different domains by our test?). Also the empirical 
information obtained with a test or another measure might show convergent and discriminant validity
when it relates to other pieces of information in a coherent way (e.g. high depression scores correlating
positively with number of days in sick leave, and negatively with life satisfaction). Then, evidence of 
concurrent and predictive validity implies that our information is actually consistent with a current or 
future criterion (e.g. an event, such as hospitalization related to severe scores of bipolar disorder). 
Depression, as many other psychological constructs, cannot be directly observed or measured in
established units, such as grams or centimeters. This is why the notions of validity and reliability10 are
crucial: in order to better describe it, we need to gather systematic evidence. Importantly, validity is not 
a property inherent to a given test or concept, but we can gather evidence of a test score or a concept 
being valid in a given context.
Applying validity to psychiatric diagnoses is not straightforward. Because of the close 
relationship between mental health and the rest of medicine, some prominent researchers in psychiatry
                                                
9 A construct is, according to the classic definition of Cronbach & Meehl (1955, pg. 283), “some postulated attribute of 
people, assumed to be reflected in test performance. In test validation the attribute about which we make statements in 
interpreting a test is a construct”.  
10 Reliability is another central concept in psychometrics. It is related to the consistency of measurement under different 
circumstances, for example across time (test-retest reliability), instruments (internal consistency and parallel forms), and 
between judges (inter-rater reliability). Reliability tightly relates to the concept of measurement error, which causes 
unsystematic variation in measurement and prediction of scores. There are numerous coefficients to calculate reliability, and 
its quantification is somewhat more straightforward than that of some forms of validity.
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seem to reduce validity to biological etiopathogenesis11 (Jablensky, 2016; Kendell & Jablensky, 2003).
Then depression (or any mental disorder) is valid only if it is a “disease entity” that is separated from the 
other diseases by “natural boundaries”. This view of validity may be easily applied to physical disorders
in other fields of medicine, but it seems a rather problematic conceptualization in psychiatry. The reason 
is that such perspective on validity emphasizes the value of neural circuitry, biomarkers, and genetic 
mechanisms. These are unarguably compelling validity criteria, as long as their role on the onset,
maintenance, or prognosis of psychopathology is empirically demonstrated. Yet, demonstrating 
etiopathogenic mechanisms does not justify disregarding other factors involved in psychopathology.
Heritability and a variety biomarkers are only a part of the variance in psychiatric disorders, of 
more or less extent and still mostly unknown (Kennis et al., 2018). Indeed, there is a heated controversy 
around the genetic contribution to depression in current literature (Border et al., 2019; Smoller, 2019).
Many factors linked to the development and course of psychiatric disorders are either not biological in 
nature, or very difficult to track directly from biomarkers. More or less complex psychological processes, 
such as attention, emotion, learning, or cognition are involved in psychopathology. In addition, cultural, 
socio-historical, and economic factors play an important role in the validity of mental illness. These 
factors may be as important as biological etiopathogenesis in explaining psychopathology, and thus 
validity studies shall reflect this etiological complexity.
Defining a diagnostic disorder or measuring it (e.g. with interviews or rating scales) is not 
particularly different from the rest of psychological measurement. Lending validity evidence of a mental 
disorder (i.e. MD) or attribute (i.e. depression) demands the same as from any other construct, such as 
empathy or consciousness. Why depression or narcissistic personality disorder, being psychological 
phenomena, should be validated under different standards? The famous five criteria for psychiatric 
validity12 compiled by Robins and Guze (1970) were guidelines originally suggested for schizophrenia, 
and seem to be incomplete for most of the contemporary diagnostic disorders because their focus was
mostly biological. Some authors have argued in favor of a wider perspective on validity of 
psychopathology (Krueger & Eaton, 2012; Lefere, De Rouck, & De Vreese, 2017).
                                                
11 In medicine, etiopathogenesis refers to the determination or study of the cause and development of a pathology, in this 
case a mental syndrome (Merrian-Webster Medical Dictionary, 2018).
12 Their so-called method for achieving diagnostic validity included five phases: clinical description, laboratory study, 
exclusion of other disorders, follow-up study, and family study.
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A main argument for revising the validity of MD is that MD informs about depression, but it is 
not depression (and this duality applies generally to psychiatric classification). MD is an index of 
depression for classification purposes, and as such it should measure what it is intended to (Kendler, 
2016). The MD diagnostic criteria do not constitute depression, constitute an index of it. As such, MD is
an instrument that conveys plenty of information. This information should be useful for diagnostic and 
treating depression effectively. However, MD being an index for depression has influence on empirical 
reality. As far as DSM criteria serve for representing reality, they also convey what we understand as 
depression (van Loo & Romeijn, 2018). For instance, MD can be seen from many theoretical angles (e.g. 
cognitive, affective-motivational dysregulation, evolutionary…), which have an influence upon
operationalization through the choice of diagnostic criteria. These theories shall be empirically tested
and validated. Collecting evidence of how diagnostic criteria function serves the purpose of studying the
validity of MD in its current definition, and may contribute to empirically-based theoretical 
developments to represent psychopathology and also non-pathological functioning (Costello, 1993).
The role of functional impairment in the severity of depression
So far there are neither biological nor structural markers to assess the severity of common mental disorder 
(Border et al., 2019; Zimmerman, Morgan, et al., 2018). Given the lack of “objective” indicators, the 
diagnostic manuals have included a requirement, known as the clinical significance criterion, to 
guarantee that a given combination of symptoms is harmful enough to justify diagnosis and consequent
treatment. Diagnostic systems consider this criterion at the same level as the symptom, duration, and 
exclusion criteria. The wording of the criterion has to some extent variation across the disorders of DSM-
5, but most often, it is described as “The symptoms cause clinically significant distress or impairment in
social, occupational, or other important areas of functioning”. The ultimate purpose of such criterion is 
to assist professionals in diagnosing more validly, by minimizing false positives (i.e. the mistake of 
diagnosing when no necessary) and false negatives (i.e. the mistake of not diagnosing when it would be 
the right choice). It is so that the clinical significance criterion makes it possible to diagnose subthreshold 
cases (i.e. fewer criteria than required) due to sufficient severity, and not to render diagnosis when criteria 
are met in a way it seems not pathological. Moreover, in the case of MD the clinical significance criterion 
plays a role in defining the severity of the syndrome, together with number of symptoms.
It was acknowledged explicitly in DSM-IV how challenging it is to evaluate this criterion: 
“Assessing whether this criterion is met, especially in terms of role function, is an inherently difficult 
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clinical judgment. Reliance on information from family members and other third parties (in addition to 
the individual) regarding the individual’s performance is often necessary” (APA, 2000, p. 7). Some 
experts have criticized such definition for being too ambiguous and somewhat redundant (e.g Maj, 2014).
This critique is supported by research evidence: full-blown cases are generally accompanied with 
disability or functional impairment in clinical samples (Zimmerman, Chelminski, & Young, 2004), and
in epidemiological studies (Beals et al., 2004; Slade & Andrews, 2002; Wakefield, Schmitz, & Baer, 
2010). Nevertheless, research has found that clinical significance-like specifiers reduced the community 
rates of mental disorders in DSM-IV and identified persons more likely to be using mental health services 
or having more severe symptoms (Narrow, Rae, Robins, & Regier, 2002). Some seminal studies on the 
impairment caused by depression showed a significant gradient of severity of impairment with number 
of symptoms, number of lifetime depressive episodes and comorbidities (Kendler & Gardner, 1998; 
Mojtabai, 2001).
On its behalf, distress as an indicator of clinical significance appears to discriminate poorly. The 
reason is redundancy to mental illness. Distress very often comes with the awareness of suffering from
psychopathological symptoms, if is not simply intrinsic to the disorder itself (e.g. anxiety disorders are 
characterized by intense distress). In the case of MD, the symptoms are themselves generally distressing 
enough to cause “marked distress” not meeting the symptom or duration requirements (Spitzer & 
Wakefield, 1999; Zimmerman et al., 2004).
The challenges experienced with the clinical significance criterion have led to some suggestions. 
One of them, proposed by Mojtabai (2001), is to include the distress and impairment ratings as 
independent components of the diagnostic system, being measured with the Global Assessment of 
Functioning (GAF) scale. This scale was replaced in DSM-5 with the WHO Disability Assessment 
Schedule (WHODAS 2.0; Üstün, 2010). On the one hand, the benefit of standard scales is to 
systematically assess impairment, and to serve both clinical and research purposes. On the other hand, 
their limitation is being general-purposed and thus not symptom- or disorder-specific. This feature 
implies the risk, particularly in research, of being confounded by other co-occurring mental or physical 
conditions than the disorder being studied. This risk is worth to ponder when investigating disorders that 
tend to be comorbid with others, such as MD. Measures of global impairment require adjustment for co-
occurring conditions if researching one disorder particularly.
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Another suggestion, made by Wakefield and collaborators (Cooper, 2013; First & Wakefield, 
2013; Wakefield, 2009), is to raise the symptom or duration criteria in order to increase their 
pathosuggestiveness. For example, given depressed mood is a relatively common symptom in the general 
population, diagnostic manuals could add an intensifying corrective to minimize false positives. Instead 
of a “blanket approach” of general impairment, which is unspecific and difficult to define for all 
disorders, the idea is to conduct disorder-specific modifications. These sort of suggestions are, 
nevertheless, difficult to carry out because of general resistance against changes to current systems in 
use.
Experts agree in severity not being reducible to symptom counts. Nevertheless, the amount of 
symptoms is predominantly used in research as single indicator of severity. Zimmerman et al. argued
that “almost all research on severity is based on scores of depression symptom scales, though most scales 
have been developed without consideration as to how to best conceptualize and assess the severity of 
depression” (2018, pp. 84). It is logical that higher sum-scores are associated with higher severity. 
However, studies have shown that symptom scores are only a sphere of severity (Lux et al., 2010; 
Zimmerman, 2012; Zimmerman, Morgan, et al., 2018), and that the correlations of symptom counts and 
proxies of severity tend to be, at their best, modest (Kitamura, Nakagawa, & Machizawa, 1993; Lux et 
al., 2010). This simplification brings about two consequences. First, other indicators of severity are less 
studied than symptom counts; and second, the use of counts conceals finely tuned information of
symptom characteristics. This information could be of clinical value, for instance in common severity 
correlates of specific symptoms. For example, it was mentioned earlier that feelings of worthlessness 
have a consistent and distinct association with suicide attempts (e.g. Bolton et al., 2008; Wakefield & 
Schmitz, 2015). This entails useful information, as compared to results claiming that a given sum-score 
in a depression scale, or a number of DSM symptoms, predict a higher probability of some outcome.
To summarize, it appears fundamental to gather information on how individual symptoms relate 
to functional impairment, which is a component of severity according to DSM-5 and undoubtedly an 
essential aspect of depression course and remission (Zimmerman et al., 2012, 2008). Evidence shows 
that the more symptoms the higher the probability of suffering from a clinically impairing syndrome. 
However, it is uncertain whether this impairment is due to the unspecific accumulation of symptoms, or 
explained to different extent by some symptoms more than by others. Furthermore, most of what we 
currently know about functional impairment of depression is based only on symptom presentation in 
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patients. Symptom distributions may differ substantially from their natural distributions in clinical 
samples, basically because clinical patients are a subset of the community. Patient samples show 
particular characteristics, not generalizable to the general population (Foster & Mohler-Kuo, 2018; 
Muthén, 1989). It would be critically important to better understand how individual symptoms relate to 
functional impairment in natural, general population samples. Knowledge on individual associations 
between symptoms and functional impairment would serve a variety of purposes, such as characterizing 
more impairing symptom profiles, delineating intervention programs targeting the most impairing 
symptoms, or informing which symptom (or duration) criteria show low ability to discriminate more 
pathological presentations.
Although we focus here in functional impairment as an indicator of severity, we acknowledge 
that conceptualizing the severity of depression, and in general of mental disorders, remains an open 
question which is much more complex than choosing one indicator or another (Zimmerman, Morgan, et 
al., 2018).
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Aims of the study
The general purpose of this doctoral dissertation was illustrating novel ways to investigate the symptom 
criteria composing MD, and their association with functional impairment in the general population. 
Concretely, the study aimed to:
I. Evaluate latent variable models of depressive symptom criteria. Inspecting whether a 
psychometric model accommodates the data sets the baseline for further analyses and has 
important implications for the interpretation of results.
II. Assess the benefit of considering individual diagnostic symptoms to inform of the severity 
of MD, as compared to sum-scores (the ‘standard’ approach). Aggregates may be efficient, 
while individual symptoms may be more explanatory. These different levels of information 
are more or less justified depending on how convenient and useful they are when set side by 
side.
III. Study symptom-specific patterns of association with self-reported functional impairment in 
the general population. The evidence on naturalistic associations, throughout the whole 
depression spectrum, is mostly lacking.
IV. Investigate whether age and gender moderate the association between specific MD
symptoms and self-reported impairment. If individual symptom-impairment patterns exist, 
are they generalizable to the community regardless of demographic variables? Demographic 
variables may help disentangling the heterogeneity observed in depression. 
V. Bring novel insights into the dependence mechanisms among MD symptoms. It is useful 
to collect evidence on symptom-to-symptom dynamics for further characterizing the
associations of depressive symptoms with functional impairment. 
The aims of the study are outlined in Figure 1.
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Figure 1. Aims of the study.
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Methods
Collaborative Psychiatric Epidemiology Surveys (CPES)
Participants 
The CPES (Alegria, Jackson, Kessler, & Takeuchi, 2015) is a large internationally available dataset of 
20 130 residents of the United States, which comprises three large, nationally representative samples of 
the general population. The goal of the CPES is to collect data about the prevalence of mental disorders,
impairments associated with these disorders, and their treatment patterns from samples of majority and 
minority adult populations in the United States. The three cross-sectional samples are composed of adults 
aged 18 and above, excluding institutionalized persons and those living on military bases. The National 
Comorbidity Survey Replication and the National Survey of American Life exclude non-English 
Speakers, but the National Latino and Asian-American Study of Mental Health focuses on participants 
who do not speak English. The response rate was 71% or higher for the three studies. For details on the 
analytic sample sizes and measures used in this doctoral dissertation, see Table 2.
The sampling methodology of the three CPES samples was highly similar, despite of some unique 
features and topical questionnaire modules. All the data collection was based on a four-stage area 
probability sampling. The primary stage sampling corresponded to counties as units or contiguous 
counties with small populations. The second stage of sampling contained geographically contiguous 
census blocks that were stratified by race/ethnicity composition of residents’ households. The  
race/ethnicity stratification of  area  segments played a particularly important role in the NSAL and
NLAAS sample designs, where it was used both to improve the sampling precision of the design and as 
a basis for more cost-effective oversampling in area segments  with  higher densities of  households for
targeted race and ethnicity subpopulations. The third and four stages of sampling involved housing units. 
The third-stage sampling rate was computed for each selected area segment in the CPES sample design. 
This rate was then used to select a systematic random sample of actual housing units from the area
segment listing. Among the eligible household members, a random selection of the respondent was 
performed using a special adaptation of the objective selection method developed by Kish (1949). In 
general, the sampling strategy was designed to optimize the cost and error properties of the study-specific 
samples. The sampling weights for data analysis compensate for differences in the inclusion probabilities 
of population members who reside inside and outside high-density area domains, and were designed to
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Table 2. Participants and measures included in the epidemiological studies used in this doctoral 
dissertation.
Study Subsample N
Measures
Depression Functional 
impairment
Other relevant 
variables
NHANES
(n=34 963)
2005-2006 5 334
PHQ-9
(referred to 
last 2 weeks)
How difficult the 
symptoms made it 
to carry out daily 
activities?
- Gender 
- Age
- Ethnicity
- Marital status
- Medical 
conditions
- Poverty 
2007-2008 5 995
2009-2010 6 360
2011-2012 5 615
2013-2014 5 924
2015-2016 5 735
CPES
(n = 20 130)
National 
Comorbidity 
Survey 
Replication
9 282 
Depression, 
module, 
WHO CIDI
(referred to 
most severe 
affective 
episode; 
n= 4 152)
- WHODAS
- Days disabled in 
the last 30 days.
- Degree of 
interference of 
symptoms
- How often unable 
to carry out daily 
activities 
- Gender 
- Age
- Ethnicity
- Number of 
symptoms
- Post-Traumatic 
Stress Disorder-
module
- Generalized 
Anxiety Disorder-
module
- Mania module
National Survey 
of American 
Life
6 199
National Latino 
and Asian-
American Study 
of Mental 
Health
4 649
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be nationally representative. For more detailed information on the sampling characteristics of CPES, see 
Heeringa et al. (2004).
The CPES samples collect information on psychopathology based on the World Mental Health 
Survey Initiative's version of the Composite International Diagnostic Interview (WMH-CIDI, Kessler & 
Ustün, 2004), which is a modified version of the Composite International Diagnostic Interview (CIDI).
The Initiative's version of the CIDI is a comprehensive, fully-structured interview designed to be used 
by trained interviewers for the assessment of mental disorders according to the definitions and criteria of 
ICD-10 and DSM-IV. It is suitable for clinical and research purposes, including measuring the prevalence 
and severity of mental disorders and assessing the burden of them. The CPES interviews were all 
computer-assisted, administered by trained personnel. Detailed information about the development and 
implementation of the CPES project can be found from Pennel et al. (2004).
Measures
Depressive symptoms
Depression has a specific section in the WHO-CIDI. Diagnostic criteria and symptoms from both DSM-
IV and ICD-10 are included in the interview. The description of the symptoms, together with the terms 
used here to refer to them are described in Table 3. Due to its breadth, the interview is based on a skip-
question system. For starting the depression module, the respondent had to answer positively to at least 
one of the screening items, reading “have you had episodes that lasted several days or longer when you 
felt…(symptom)” and one of the following: “sad, depressed or empty”, “discouraged”, “loss of interest”,
or “life had no meaning”. If the respondent endorses one of these screening questions, the depression 
module is administered. It symptoms are asked concerning “think of the period when your 
sadness/discouragement/lack of interest and other problems were most severe and frequent. Did 
you…(symptom)”. The answers are coded as “yes”, “no”, “does not know”, and “refuses”. While 
administering the depression module, several checkpoint filters determine whether to continue or not 
with the module. All the items corresponding to the DSM-IV symptom criteria were assessed rather 
precisely (e.g. compound items divided into several parts). However, the module was only continued 
when the participant had endorsed the stepwise screening process, and therefore information on sleep 
problem, for example, is missing if the participant did not endorse any of the screening symptoms. 
Likewise, the items concerning suicidal behaviour are only administered when the participant has 
endorsed items concerning death thoughts. This process leads to data missing not at random (MNAR), 
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and therefore imputation is not a feasible option. The size of the analytic sample for the depression 
module was n=4 152. The weighted frequencies of the DSM-IV symptom criteria are presented in Table 
4. Note that the items concern the most severe period of depressive syndrome, and not lifetime symptom 
endorsement patterns. 
Functional impairment
Functional impairment is assessed in the CPES with two general measures and other two which are 
specific of the affective episode. The World Health Organization Disability Assessment Schedule 
(WHODAS) is a 36-item questionnaire which measures health and disability as defined in the 
International Classification of Function, Disease and Health (WHO, 2018). Scores are a product of 
frequency and severity of problems (none, mild, moderate, severe) that respondents reported 
experiencing in the past 30 days, and are normalized to values ranging from 0 to 100, where higher 
numbers indicate worse functioning. The scale is divided into six domains of functioning: cognition, 
mobility, self-care, social interaction, role functioning, participation (Üstün, 2010). The scale is 
considered a generic assessment instrument for health and disability. This scale was referred to current 
functioning. In psychiatric literature both terms, impairment and disability, are used with no distinction 
(e.g. Sheehan, Harnett-Sheehan, & Raj, 1996). We may use the terms indistinctively as well. 
A second indicator of general impairment is the item "Beginning yesterday and going back 30 
days, how many days out of the past 30 were you totally unable to work or carry out your normal activities 
because of problems with either your physical health, your mental health, or your use of alcohol or
drugs?". Participants quantified days from 0 to 30. Both of these generic indicators of functional 
impairment were collected of all participants of CPES.
The depression module of the interview contained two items querying the level of functional 
impairment and life interference caused by the depressive episode. The depressive episode reported is 
the most severe ever suffered by the participant, which is recalled in terms of symptom manifestation 
and impairing consequences. The first item concerns life interference of the symptoms, with the wording 
“You mentioned having [(two of/a number of)] the problems I just asked you about. How much did your 
sadness/discouragement/lack of interest and these other problems interfere with either your work, your 
social life, or your personal relationships during that episode?”, and response categories  “not at all”, “a
little”, “some”, “a lot”, and “extremely”. 
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Table 3. Depressive symptoms examined in the study.
Shortened term WHO-CIDI descriptors PHQ-9 descriptors
Depressed mood Sad, empty, depressed, hopeless 
about future, nothing could 
cheer up
Down, depressed, hopeless
Anhedonia Lost interest, nothing fun when 
good things happened
Little interest or pleasure in 
doing things
Appetite changes Weight loss/gain not trying, 
much smaller/larger appetite
Poor appetite, overeating 
Sleep problems Trouble sleeping, slept much 
more than usual
Trouble falling asleep, staying 
asleep, sleeping too much
Psychomotor disturbances Talk/move more slowly than 
usual, others noticed, so restless 
that could not stay still 
So slowly that others could 
notice. Or the opposite -
fidgety, restless
Fatigue Low energy and tired for no 
reason
Tired, little energy
Self-criticism Worthless feeling, felt guilty Bad about yourself, failure, let
down self or family
Difficulties to concentrate Trouble concentrating, unusual 
indecisiveness 
Trouble concentrating on 
things, such as reading 
newspaper or watching TV.
Thoughts of death or self-harm Thought of death, better dead, 
suicide thoughts, plan,
attempted
Better off dead, hurting yourself 
in some way
If the respondent stated that, at least, the symptoms had interfered “a little” with their life, a 
second items would follow: “How often during that episode were you unable to carry out your daily 
activities because of your sadness/or/discouragement/or/lack of interest?”. The item has the following 
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response options: “never”, “rarely”, “sometimes”, and “often”. We dichotomized these items, so that 
they would be indicators of severe functional impairment by reflecting whether items had interfered “a 
lot” and “extremely” with life, and whether the respondent could not carry out her daily activities “often”. 
These items were only posed to participants who had endorsed the screening questions of the depression 
module, and were referred to the time of the worst affective episode. The 55.6% of the participants asked 
responded they had suffered a lot or extreme interference, while 28.9% reported being often unable to 
get by in daily life.
Other psychiatric disorders 
Three other diagnostic categories were examined additional to MDE. These were General Anxiety 
Disorder (GAD, n=3 610), Manic Episode (ME, n=4 214), and Post-Traumatic Stress Disorder (PTSD, 
n=3 128). All of them followed the same skip-question system and therefore the modules were only 
administered when endorsing at least one of the screening symptoms. An index was computed for each 
of the disorders indicating how many DSM-IV criteria the participant had endorsed. These sum-scores 
ranged from 0 to 12 for MDE 0 to 7 for GAD, 0 to 16 for ME, and from 0 to 16 in the case of PTSD.
Other relevant variables
We adjusted our analyses for variables such as gender, years of age, ethnicity, marital status, and number 
of chronic medical conditions.
National Health and Nutrition Examination Survey (NHANES)
Participants
The National Health and Nutrition Examination Survey (NHANES) is a program of studies designed to 
assess the health and nutritional status of adults and children in the United States. This is a major program 
belonging to the Centers for Disease Control and Prevention (CDC, 2017), which provides official 
statistics of the United States. The purpose of the data is to be used in epidemiological studies and health 
research, which help develop sound public health policy, and design health programs and services. In 
1999, the survey became a continuous program that has a changing focus on a variety of health and 
nutrition measurements to meet emerging needs. The survey examines a nationally representative sample 
of about 5 000 persons each year. The NHANES project includes demographic, socioeconomic, dietary, 
and health-related matters including medical, dental, and physiological measurements.
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A four-stage sample design was implemented in the NHANES samples included in this doctoral 
dissertation. The primary sampling units were counties, selected with probabilities proportional to size. 
The second sampling stage comprised area segments based on census blocks. The third stage were 
dwelling units. The fourth state of sampling involved households. The sampling procedure in the third 
and fourth stages sought at maximizing the sampling objectives of the studies (representativeness of race, 
origin, sex, income, age). The sampling weights were designed to meet the following objectives: (1) 
compensate for differential probabilities of selection due to race and Hispanic origin, income, sex, and
age; (2) reduce biases arising from differences between respondents and non-respondents; (3) match an 
independent U.S. Census Bureau estimate of the population; (4) compensate for inadequacies in the 
sampling frame; and (5) reduce variances in the estimation procedure. Further details of the sampling 
and weighting methodology can be found from the website of NHANES (CDC, n.d.)
We selected the samples which include the depression screener questionnaire for this dissertation, 
the waves of 2005-2006, 2007-2008, 2009-2010, 2011-2012, 2013-2014, and 2015-2016. For details on 
the sample sizes and measures see Table 2. The analytic sample consisted of n=21 056 observations.
Measures 
Depressive symptoms
The depression screener is the nine-item version of the Patient Health Questionnaire (PHQ-9; Kroenke 
& Spitzer, 2002). This questionnaire is administered to all participants aged 18 or older in the NHANES 
study, as part of computer-assisted personal interviews. The nine items of the questionnaire query how 
often the participant had been suffering from concrete depressive symptoms during the last two weeks, 
each self-rated on a four-point response scale (0=Not at all, 1=Several days, 2=More than half the days, 
3=Nearly every day). The nine symptoms correspond to the MD symptom criteria in DSM-IV. The 
scoring system of PHQ-9 can be interpreted according to the cut-points of 5, 10, 15 and 20, indicative of 
mild, moderate, moderately severe and severe levels of depressive symptoms (Kroenke & Spitzer, 2002; 
Kroenke et al., 2010). The weighted frequencies of the PHQ-9 items (which correspond to the DSM-IV 
symptom criteria for MD) are presented in Table 2.  It is worth to mention that PHQ-9 does not include 
any filtering conditional on symptom endorsement. 
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Table 4. Response frequencies of the DSM diagnostic symptoms of Major Depressive Disorder in the 
datasets included in the study.
DSM-IV
symptom criteria 
CPES (WHO-
CIDI) NHANES (PHQ-9)
Yes (%) Several days (%) More than half 
the days (%)
Nearly every day 
(%)
Depressed mood 90 16 3 3
Anhedonia 83 16 4 3
Appetite changes 70 15 4 4
Sleep problems 88 24 7 8
Psychomotor 
disturbances
10 7 2 1
Fatigue 81 35 8 8
Self-criticism 60 12 3 2
Difficulties to 
concentrate 
85 11 3 3
Thoughts of death 
or self-harm
66 2 1 <.1
Functional impairment
The PHQ-9 contains an additional item addressing the question “if you checked off any problems, how 
difficult have those problems made it for you to do your work, take care of things at home, or get along 
with other people?”. Functional impairment is therefore measured specifically as a result of the
depressive symptoms the respondent has endorsed. Like the rest of PHQ-9 items, it is rated on a four-
point Likert scale (0=Not difficult at all, 1=Somewhat difficult, 2=Very difficult, 3=Extremely difficult). 
Depending on the analyses, the four original ratings or two categories were examined (joining categories 
0 and 1, and categories 2 and 3). This single item is considered a measure of functional impairment which 
correlates strongly with a number of quality of life, functional status and health care usage variables 
(Kroenke & Spitzer, 2002b, pp. 1–2). We dichotomized the item by merging the two lowest and two 
highest categories. The reason was achieving an indicator or functional impairment severe enough to 
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screen for clinical relevance (i.e. here having it “very” or “extremely” difficult to carry out normal 
activities).
Other relevant variables
Other variables considered were gender (reported as “Male” or “Female”), age (both in years and 
categorized into four groups: 18-30, 31-50, 51-65, and 65 and older), race/ethnicity (1=Mexican 
American, 2=other Hispanic, 3=non-Hispanic white, 4=non-Hispanic black, or 5=Other including multi-
racial), marital status (1=married, 2=widowed, 3=divorced, 4=separated, 5=never married, 6=living with 
partner), ratio of family income to poverty (dichotomized with a threshold at 1, informing of whether the 
income of a household is below or above the poverty level), a count variable of self-reported medical 
conditions (including diabetes, heart disease, stroke, pulmonary disease, and cancer), and NHANES 
sampling cohort (2005, 2007, 2009, 2011, 2013, and 2015).
Statistical analyses
Regression models
Several regression models were used for predicting indicators of functional impairment in Studies I and 
II. In the regression models, predictors at the disorder level (i.e. sum-scores) and symptom level (e.g. 
most severe symptom, endorsement of symptom) were included. The results were adjusted for age, 
gender, and ethnic background. Some models were additionally adjusted for number of physical 
chronic diseases, living below the poverty threshold, and civil status. If not stated otherwise, 
statistically significant results are interpreted here with respect to a confidence level of α = .05.
Functional impairment was a markedly skewed variable in the community datasets included in 
this dissertation. Consequently, the following models were used:
- Censored regression model. When outcome variables show high frequency of floor values, these 
models truncate the predictions at the lowest value of the observed distribution, while modelling the 
underlying variable according to a given distribution (e.g. normal, student, logistic). Censored regression 
models are a generalization of the tobit model (Tobin, 1958).
We defined the lower and upper boundaries of the models so that the predictions would range between 
the possible values of the outcome (e.g. days disabled in a month range usually from 0 to 30). The model 
assumes a latent variable ݕ௜∗, and its predictions ݕ௜ depend on the following constraint:
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ݕ௜ = ቐ
ݕ௟ ݂݅ ݕ௜
∗ ≤ ݕ௟
ݕ௜
∗ ݂݅ ݕ௟ < ݕ௜
∗ <  ݕ௨ 
ݕ௨ ݂݅ ݕ௜
∗ ≥ ݕ௨
.
The latent variable ݕ௜∗ is estimated following the model:
ݕ௜
∗ =  ߙ +  ߚݔ௜ +  ݑ௜,   
where α is the model intercept, ݔ௜ is the vector of linear predictors, and ߚ the parameter vector of 
regression weights. The error term ݑ௜ is distributed normally with mean zero and dispersion ߪଶ. As with 
any other linear regression model, a link function ݃(ߤ) can be chosen to define the relationship between 
the linear predictor component and the mean of the distribution function, ߤ. The R package crch versions 
1.0-0 and 1.0-1 were used (Messner, Mayr, & Zeileis, 2016). The multi-stage sampling weights from the 
CPES data were not used for not being implemented in the package.
- Logistic regression model. This model is often used when modeling a binary dependent variable.
The model uses most often the logit function as the link function (i.e. ݈݋݃݅ݐ ܧ(ݕ) = ߙ + ߚݔ). In this case, 
the regression weights contained in ߚ are log-odds of the probability of an event (i.e. ݕ = 1). The log-
odds (i.e. natural logarithm of the odds) can be converted into odds by exponentiating them: 
݋݀݀ݏ(ܻ = 1) =  ݁ఈାఉ௫ =  
ߨଵ
1 − ߨଵ
ൗ .
Where ߨଵ is the probability of the event happening, and 1-ߨଵ, also ߨ଴, the probability of the 
complement of the event (i.e. the event not happening: ߨଵ +  ߨ଴ = 1). The interpretation in terms of odds 
ratios is straightforward by exponentiating the regression coefficient of a given predictor x (i.e. ܱܴ =
 ݁ఉ௫). For example, for a particular depressive symptom with a response yes/no, we can estimate what 
are the odds of suffering from high functional impairment when endorsing such symptom (i.e. percentual
difference expected to report high impairment having the symptom, as compared to not endorsing the 
symptom). For instance, an odds ratio of ܱܴ = exp ߚመ =  ݁ଵ.଼ଽ = 6.62 would mean that reporting the 
symptom X is associated with high functional impairment by a factor of 6.62, as compared to reporting 
no such symptom.  
We provided some indices informing of the regression models. Aikaike’s Information Criterion 
(AIC) is a fit index that penalizes for model complexity (Burnham & Anderson, 2002). AIC was used 
for comparing non-nested models. A lower AIC is indicative of a better fit or higher parsimony.
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Nagelkerke’s pseudo R2 was also providad, which is asymptotically independent of the sample size and 
can be interpreted as the proportion of the outcome variation explained by the predictors. Pseudo R2
values range between 0 and 1 (Nagelkerke, 1991).
There is a phenomenon known as class imbalance, which implies that statistical learning 
algorithms have estimation difficulties when a minority class has too few observations available. In the 
case of logistic regression, this problem seem to be worrisome when the absolute amount of observations 
is too little, while the magnitude of the imbalance itself does not play such a big role (e.g. the ratio). For 
instance, a binary outcome with probabilities 96 and 4% means about 1 398 observations severe reporting 
impairment in the overall NHANES data, which seems to be large enough to not to fall too short of
information. In the case of very rare events, it has been recommended to collapse categories if theoretical 
considerations support the decision (Tabachnick & Fidell, 2013). We did therefore collapse the NHANES 
item assessing functional impairment into two categories, otherwise single categories would be 
problematic due to insufficient amount of observations compared to the amount of predictors in our 
models.
Severe class imbalance is important in predictive modeling. Its consequences in descriptive 
modeling, which is the case here, are not so far-reaching. The bias introduced in a model with severe 
class imbalance concerns mostly the intercept, and not particularly the slope estimates. This implies risk 
of deflated predictions, but no substantial risk of bias in terms of predictor-outcome associations (King 
& Zeng, 2001; Owen, 2007). In our data analysis approach, the potential effect of severe class imbalance 
is the underestimation of the likelihood of severe impairment (i.e. underestimation of the intercept), but 
the statistical differences seen between demographic groups, the key aspect for our aims, are not in risk 
of being underestimated. In sum, logistic models are rather robust to severe class imbalance (Alkhalaf & 
Zumbo, 2017), and therefore seem suitable for the characteristic variables in psychopathology. The 
package survey version 3.33-2 (Lumley, 2019) was used for regression models for its treatment of 
complex sampling weights of both CPES and NHANES surveys.
Item Response Models
Mental disorders are typically treated as single diagnostic syndromes, conveying unidimensionality. This 
assumption is characteristic for the reflective framework, meaning that a latent variable (e.g. depression 
liability) explains the covariation among the observed variables (i.e. items). The two-parameter logistic 
model was used:
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݌൫ݔ௝ = 1|ߠ, ߙ௝, ߜ௝൯ =  
݁ఈೕ(ఏିఋೕ)
1 + ݁ఈೕ(ఏିఋೕ)
 ,
where ߠ is the parameter corresponding to the level of trait for a person (e.g. depression), and αj and δj
are the item j’s parameters. The δ parameter is said to measure the difficulty or severity of j (i.e. level of 
ߠ required for a .50 probability of endorsing an item). The α parameter informs of the discrimination of 
the item (i.e. the slope of the curve at its inflection point, δj). The δ parameter is especially interesting for 
psychopathology for estimating the level of the trait associated with endorsing a given symptom. Those 
symptoms with a higher δ imply a more severe expression of the underlying disorder or trait continuum 
(e.g. ߠ interpreted as depression). Item response models are well documented, for example, by de Ayala 
(2013) and Reckase (2009), and will not be further elaborated here. We may refer explicitly to 
psychometric severity of a symptom or item, meaning particularly this IRT-based estimate of severity.
The symptom criteria of MD present an exceptional case due to strong negative correlations 
among paired poles of symptoms (weight gain-loss, hypersomia-insomnia, motor retardation-agitation), 
and thus a two-tier bifactor model was fit, in which only the parameters corresponding to the general 
factor (i.e. those capturing the common variation) were used. See Cai (2010) for technical details on the 
Item Response Bifactor model. Item Response models were part of the Study I. The R package mirt 
version 1.21 (Chalmers, 2012) was used for the analyses.
Differential Item Functioning (DIF)
The purpose of DIF is testing psychometric bias. DIF methods assess whether some items (e.g. 
symptoms) behave differently across population sub-groups (e.g. age or gender) when adjusting for 
possible differences in the trait (e.g. depression). These analyses were used in Study II.
DIF testing consisted on fitting three logistic regression models, which were nested, for each item 
(i.e. symptom). For example, in the case of examining DIF with respect to gender in binary items:
ܯ݋݈݀݁ 1: ݈݋݃݅ݐ ܲ(ݕ௜ = 1) =  ߙ +  ߚ௜ ∗ ݐݎܽ݅ݐ
ܯ݋݈݀݁ 2: ݈݋݃݅ݐ ܲ(ݕ௜ = 1) =  ߙ +  ߚଵ ∗ ݐݎܽ݅ݐ +  ߚଶ ∗ ݃݁݊݀݁ݎ
ܯ݋݈݀݁ 3: ݈݋݃݅ݐ ܲ(ݕ௜ = 1) =  ߙ +  ߚଵ ∗ ݐݎܽ݅ݐ + ߚଶ ∗ ݃݁݊݀݁ݎ +  ߚଷ ∗ ݐݎܽ݅ݐ ∗ ݃݁݊݀݁ݎ
.
DIF detection is carried out by comparing the three models (Models 1 vs. 3, 1 vs. 2, and 2 vs. 3).
There are three two types of DIF. Uniform DIF corresponds to the case of a given group systematically 
more or less likely to endorse an item, regardless of their attribute level. Thus, the bias is constant across 
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all levels. Non-uniform DIF, differently, occurs when the probability of item endorsement varies 
according to the level of attribute of the groups, and thus the bias is not constant. Uniform DIF can be 
tested by comparing Models 1 and 2, and non-uniform DIF can be examined by comparing Models 2 and 
3 (note it involves an interaction to model the non-constant bias, otherwise modeled with a main effect 
for uniform DIF). An overall test of DIF consists of comparing Models 1 and 3. The criterion for DIF-
flagging was a change in Nagelkerke’s R2  ≥ 0.02 (Gelin & Zumbo, 2003). A change in the index indicates 
that the model accommodates differently to the observed data, and thus implies DIF if the improvement 
introduced by the DIF-related regression estimates is substantial. The analyses were performed with the 
R package lordif (Choi, 2016).
Confirmatory factor analysis and tetrad constraints
Confirmatory factor analysis is a very common statistical method in psychological modeling. This 
technique estimates scores on a latent variable (i.e. directly unmeasurable), such as depression or verbal 
aptitude, based on observed scores on a test. 
Only the essential information concerning the purposes of this dissertation will be presented here, 
for a deeper view refer, for example, to Brown (2015). The measurement equation for a unidimensional 
factor model is:
ܺ௜௝ = ߣ௝ߦ௜ +  ߜ௜௝ ,
where the observed score X of participant i in item j (also known as indicator) is modeled as a result of 
the loading λ of the item j on the latent factor ξ (e.g. depression) and an error term δ. An assumption of 
the model is local independence, which entails that the covariations among the indicators of a latent 
factor (e.g. the items of a questionnaire measuring a single trait) are only due to the latent factor 
underlying them. Put differently, the indicators in a one-factor model are independent of each other 
conditional on the latent factor (ߩ௑ೕ௑ೕᇲ|క = 0). Spearman, who developed factor analysis to model 
intelligence in 1904, arrived to this solution in order to make the model identifiable. 
The structural operationalization of local independence roots from the principle of vanishing 
tetrads. A tetrad is a difference between a product of one pair of covariances and a product of another 
pair, among four random variables (i.e. the determinant of a 2 x 2 sub-matrix of their full covariance 
matrix). Three tetrads (τ) can be derived from a set of four random variables (e.g. items in a 
questionnaire):
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߬ଵଶଷସ = ߪଵଶߪଷସ − ߪଵଷߪଶସ,
߬ଵଷସଶ = ߪଵଷߪସଶ − ߪଵସߪଷଶ,
߬ଵସଶଷ = ߪଵସߪଶଷ − ߪଵଶߪସଷ,
where ߪଵସ refers to the population covariance between the first and fourth variables (i.e. items). Of these 
three tetrads each one is linearly dependent of the other two. A vanishing tetrad is one that equals zero 
in its evaluated value13. Factor analysis requires a number of model equations that can be solved only 
when these tetrad constraints are included. A reflective structural model with one latent factor (i.e. 
unidimensional factor model) implies that all the tetrads are vanishing, whereas non-vanishing tetrads 
will be present if the variables fit to a mixed or purely formative measurement model (e.g. a network 
model). If the tetrads differ too much from zero, then the reflective model does not properly accommodate 
the data. For a thorough review, the reader can turn to Bollen and Bauldry (2011).
The principle of vanishing tetrads is structural, and independent of the distribution of the variables 
or the values of the parameters (i.e. does not depend on data being Gaussian or having any other specific 
distribution). In the general linear model, the covariance between the latent factor ߦ and the residuals is 
ܥ݋ݒ൫ߦ, ߜ௝൯ = 0 for all variables j, and ܥ݋ݒ൫ߜ௝, ߜ௞൯ = 0 for j≠k. ߣ௝ is the factor loading of ݆ onto ߦ.
Then, it follows that  ܥ݋ݒ൫ ௝ܺ = ߣ௝ߦ +  ߜ௝, ܺ௞ = ߣ௞ߦ +  ߜ௞൯ = ܥ݋ݒ൫ߣ௝ߦ, ߣ௞ߦ൯ +  ܥ݋ݒ൫ߣ௝ߦ, ߜ௞൯ +
 ܥ݋ݒ൫ߜ௝, ߣ௞ߦ൯ +  ܥ݋ݒ൫ߜ௝, ߜ௞൯ =  ߣ௝ߣ௞ܥ݋ݒ(ߦ, ߦ) =   ߣ௝ߣ௞ܸܽݎ(ߦ).
This implies that all ܥ݋ݒ൫ ௚ܺ, ܺ௛൯ × ܥ݋ݒ൫ܺ௜, ௝ܺ൯ and ܥ݋ݒ൫ ௚ܺ, ܺ௜൯  × ܥ݋ݒ൫ܺ௛, ௝ܺ൯ are both equal 
to ߣ௚ߣ௛ߣ௝ߣ௞ܸܽݎ(ߦ)ଶ, and the difference between them is zero for all tetrad equations under this model. 
If, for example, ௚ܺ and ܺ௛ are locally dependent (i.e. violate the model), this adds a unique component 
ܥ݋ݒ൫ߜ௚, ߜ௛൯ ≠ 0 to the ܥ݋ݒ൫ ௚ܺ, ܺ௛൯, and therefore it is very unlikely that ܥ݋ݒ൫ ௚ܺ, ܺ௛൯ × ܥ݋ݒ൫ ௝ܺ, ܺ௞൯ =
 ܥ݋ݒ൫ ௚ܺ, ௝ܺ൯  × ܥ݋ݒ(ܺ௛, ܺ௞).
The tetrad tests were used in Study III under the following rationale. The symptom criteria in the
operational definition of MD are very heterogeneous, covering somatic, affective-motivational and 
cognitive symptoms. It is rather unlikely that a single latent variable exhaustively underlies all these 
                                                
13 The determinant of a square matrix M of order 2 is denoted by |ܯ| and is calculated as: |ܯ| = det ൬൤
݃ ℎ
݆ ݇
൨൰ = ݃݇ − ℎ݆.
The determinant of a matrix M will be zero if and only if there exists a λ such that g=λj and h=λk. 
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symptoms, and therefore we chose a group of symptoms that more plausibly reflect a common trait, or 
directly relate to each other. These symptoms are specific from MD in the sense that they do not overlap 
with other disorders, and often feature core descriptions of the syndrome. The symptoms we focused on 
are depressed mood, anhedonia, self-criticism, and death thoughts. The used the model-implied tetrads 
for conducting a confirmatory bootstrapped test following the work of Bollen and Ting (1998; 1993).
We wrote the script in R, being part of it based on functions of the R package lavaan, version 0.6-2
(Rosseel, 2012).
Confirmatory Factor Analysis (CFA) was also performed in Studies I and III with the package 
lavaan. We evaluated model fit according to the customary indices and thresholds. The following cut-
off values indicate acceptable fit: RMSEA ≤ .06, CFI ≥ .95, and SRMSR ≤ .08 (Hu & Bentler, 1999; 
Kline, 2015).  RMSEA (Root Mean Square Error of Approximation) and SRMSR (Standadized Root 
Mean Square Residual) are absolute measures of fit, which is better as the estimate decreases. The CFI 
(Comparative Fit Index) is an incremental measure and pays a penalty for every parameter estimated. An 
increase in the measure suggests better fit. 
Linear Non-Gaussian Acyclic Model (LiNGAM)
The LiNGAMs were developed to infer dependence structures from cross-sectional, observational data. 
In the most basic setting, the LiNGAM models make the following assumptions: (i) the data generating 
process is linear, (ii) there are no unobserved confounders, and (iii) residuals have non-Gaussian 
distributions of non-zero variances, so that the dependence relations between variables can be modeled 
for a single observation (e.g., study participant) in matrix form as:
࢞ = ࣆ + ࡮࢞ + ࣕ,    
where the vector ࣆ contains the constants and the strength matrix B collects the regression coefficients. 
The vectors x and ࣕ include the observed variables and residual terms respectively. Assuming an acyclic 
structure (Bollen, 1989), it can be shown that it is always possible to perform simultaneous permutations 
on the connection strength matrix B to render it strictly lower triangular. “Acyclicity” entails the absence 
of feedback loops among variables, meaning their association pattern represents a directed flow of 
information. 
In the example
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the variable  ݔଶ is equal to its residual ߳ଶ , and therefore “exogenous” since it is not affected by the other 
observed variables, neither ݔଵ nor  ݔଷ. In general, an exogenous variable is not predicted by other 
observed variables in the system, but in turn, it can be considered as an input to the system of variables. 
The next variable in the causal ordering is ݔଷ, as it is directly influenced by the exogenous variable, and 
the last one in the causal chain is ݔଵ. Once the matrices are permutated according to the causal ordering 
(B to lower triangular), we find:
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This model is depicted in Figure 2. The goal of the algorithms applying LiNGAM is to estimate 
the B matrix from the data in order to infer direct causal associations. The A matrix, also computable, 
contains the total effects (direct and indirect) between the variables (Hoyer, Shimizu, Kerminen, & 
Palviainen, 2008).
The DirectLiNGAM algorithm
Many LiNGAMs are related to Independent Component Analysis (ICA), which is a computational 
method used to separate a multivariate signal into additive components. These components are 
understood as latent factors that underlie the observed multivariate variable (Hyvarinen, Karhunen, & 
Oja, 2001). ICA-based and gradient-based LiNGAM algorithms are iterative, which poses some potential 
stability problems. In order to avoid these problems, Shimizu and colleagues introduced a more direct 
method, called DirectLiNGAM, which does not require potentially unstable iterative gradient ascent 
algorithms (Shimizu et al. 2006; Shimizu et al. 2011). The algorithm estimates the A and B matrices by 
first identifying one exogenous variable and removing its effect from the other variables by means of 
least squares regression, then again searches for the next exogenous variable and continues until a 
dependence ordering is established. When simplified to the pairwise setting in our illustration, we will 
generally refer to the independent variable as X and to the dependent as Y. The algorithm does not ‘know’ 
which is which and aims to distinguish between two systems of equations, either 
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൜
X = ߤ௑ + ߳௑
Y = ߤ௒ + βX + ߳௒
or      ൜X = ߤ௒ + βY + ߳௑
Y = ߤ௒ +  ߳௒
.
The residuals ࣕ = (߳௑, ߳௒) follow non-Gaussian distributions with zero mean and non-zero variance, and 
they are jointly independent. Based on the model assumptions and on the Darmois-Skitovich theorem, 
the independent or antecedent variable is the variable that is more independent of its residual (Shimizu 
et al. 2011). That is, we can define ܯܫ^ (ܺ, ߳௬) as an estimate of mutual information 
Figure 2.Example of Directed Acyclic Graph (DAG).
between ܺ and the residual of Y when regressed on ܺ, denoted ߳௒. The algorithm uses a nonparametric 
kernel-based estimate of mutual information. Bivariate mutual information quantifies how much 
information about one variable can be obtained through the other. This measure is based on the concept 
of information entropy, which quantifies the amount of information held in a random variable. Pairwise 
mutual information can be understood as a degree of departure from bivariate independence. It is 
important to notice that mutual information relates to all dependence, linear and nonlinear, whereas the 
Pearson product-moment correlation only entails linear dependence. For this reason, DirectLiNGAM can 
make use of higher statistical moments than covariances and surpasses traditional structural equation 
models in what comes to causal discovery. For a detailed review on the mathematical grounds of the 
algorithm, we refer the reader to the original papers by Shimizu and colleagues (Shimizu et al., 2011; 
Shimizu et al., 2006).
Simulation studies on the performance of DirectLiNGAM  
DirectLiNGAM has shown promising performance in simulation studies and with real-world datasets 
(Rosenström et al., 2012; Rosenström & García-Velázquez, in press; Shimizu et al., 2011). We performed 
a brief simulation study to inspect how the DirectLiNGAM algorithm performs in circumstances realistic 
of research in psychopathology and psychiatric epidemiology.   
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We examined the detection success of DirectLiNGAM with ordinal variables. This is because the 
LiNGAM methods have been developed for continuous variables, which have more variability and more 
accurately defined units than the ordinal-valued (Likert-type) variables. Ordinal items are used very 
commonly in psychological questionnaires, such as the Patient Health Questionnaire included in 
NHANES studies. Rosenström et al. (2012) conducted a simulation study by categorizing continuous 
variables and preserving their scale, while varying several parameters like sample size and number of 
categories. The estimation performance of the algorithm was nearly flawless. More detailed simulation 
studies are needed so that users know the performance of the DirectLiNGAM algorithm with those 
research conditions typical of psychopathology. This is important, because using an ordinal level of 
measurement for a supposedly continuous underlying variable in survey questionnaires may alter the 
underlying ‘true’ scale or unit of that variable, which can lead to serious problems in statistical modeling 
of multiple variables (e.g. Kang & Waller, 2005). This possibility is especially alarming for distribution-
based inference because transformations of scale also alter observed distributions.
Thus, in study III we addressed different aspects of ordinal variables, such as the number of 
categories (two to seven), and the type of categorization (even categorization, doubling the number of 
categories in either variable and adding noise to alter the grid for categorization). The study was 
conducted on several sample sizes (from 100 to 5000) and replicated 2000 times per setting to estimate
the proportion of success.
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Results
Psychometric modeling of the symptom criteria of depression
Two of the studies in this dissertation implemented latent variable models of depression. In Study I we 
presented a bifactor 2-parameter logistic item response (IRT) model. The bifactor model is characterized 
by all indicators loading on a general factor, and several specific factors accounting for the remaining 
shared variance among subsets of items. By means of a bifactor structure we modeled a general latent 
trait (i.e. depression), estimating separately the local dependencies between item pairs due to strong 
negative correlations between the opposed symptom criteria (e.g. excess and decrease in appetite or sleep,
so-called compound criteria composed by the two extremes). The fit of this model was acceptable 
(RMSEA = .056, CFI = .937, SRMSR = .048) according to the customary thresholds for structural 
equation modeling.
The IRT models include an estimate of item severity that can be useful in studies of criterion 
validity. These severity estimates, in our analyses, corresponded to the general factor (i.e. were free from 
other sources of covariance, such as the aforementioned compound-criteria correlations). The latent trait 
(general factor in bifactor models, represented as ߠ) is generally estimated under the assumption of 
normality in IRT, implying that the 95% of the population scores are contained within the range ߠ= 
{±1.96}. A high severity estimate means that it is required as high ߠ to endorse the item with a 50% 
likelihood. The IRT models of the four disorders tested in Study I (GAD, ME, MDE, PTSD) reflected, 
in general, a rather clear dose-response association between psychometric severity and the impairment
indicators (WHODAS scale and disability days). Moreover, psychometric severity was predictive of the 
impairment indicator (WHODAS scale) in regression analyses independently of the symptom counts. 
Such result can be understood as evidence of concurrent validity for the severity estimates. The same 
behaviour of psychometric severity estimates was seen for all diagnostic disorders with the exception of 
MD, which model showed some suboptimal characteristics worth to describe here. 
First, the severity estimates of MDE symptom criteria in the model registered some very deviant 
values for three items (weight gain, hypersomnia, and motor agitation). The large magnitude of the 
estimates of these three items suggests there may be something wrong with the model (Reise & Waller, 
2009). Second, the fact that the severity estimates do not predict the WHODAS scores in regression 
model of MDE does not support the use of the psychometric severity estimates. The unidimensional 
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bifactor IRT model of MDE did not perform as a useful model and showed some signs of computational 
inadequacy.
In Study III, we explicitly tested the plausibility of a reflective model in the NHANES data. Only 
the four items specific to the diagnosis of MD were included (i.e. anhedonia, depressed mood, feelings 
of self-criticism, and thoughts of death and self-harm). Across the separate analyses conducted on the six 
comparable NHANES samples, the bootstrapped confirmatory tetrad analyses indicated invariably that 
a reflective model did not accommodate the data well (highest bootstrapped p-value = .0025). This means 
that the items have associations among them, which are not captured adequately by the single latent 
factor.
Individual symptom criteria as compared to their sum-scores
After the difficulties observed in Study I for the latent estimates of MDE, we proceeded to examine 
observed variables only. Observed variables can be studied separately (individual depression criteria) 
or as aggregates (scale scores or symptom counts). We approached this topic in Study II by conducting 
several regression models, which included a wide variety of relevant covariates (among them the 
number of physical conditions and risk of poverty). We first computed a baseline model, where the 
PHQ-9 sum-score was specified as predictor of high depression-related functional impairment. In a 
posterior series of models, the PHQ-9 items were modeled separately and their independent association 
with the same dependent variable was estimated. According to the results, the model including all the
individual symptoms fits the data better than the one using the sum-score in terms of AIC (4563.42and 
4574.57, respectively) and Nagelkerke’s pseudo R2 (.331 and .316).
Associations of individual symptom criteria with self-reported functional impairment
This question was comprehensively targeted in Study II by means of several regression models, which 
were adjusted for relevant covariates to depression. Five symptoms (i.e. symptom criteria) showed a 
positive association with severe impairment after adjusting for all other symptoms simultaneously plus
covariates. The symptoms were anhedonia, depressed mood, fatigue, concentration difficulties, and 
psychomotor problems. The higher the score on the symptoms, the most likely it was that a person 
suffered very or extreme difficulties to carry out normal life. The main effects in a generalized linear 
model can be added to each other to estimate the cumulative probability of endorsing the outcome. The
unique contribution of each of these symptoms to the model’s Nagelkerke’s R2 ranged from 3.0 to 4.3%, 
58
suggesting that the association between individual symptoms and high functional impairment was mostly 
unspecific (i.e. symptoms mostly overlapped with each other in the variance shared with the outcome).
There were three symptoms that did not predict high functional impairment under a significance 
level of α=.05. The symptoms were sleep problems, appetite changes, and thoughts of self-harm and 
death. These symptoms showed a significant effect on the single-symptom regression models, which 
disappeared after adjusting for the effects of the other symptoms. This suggests that they lack association 
with functional impairment independently.
We will examine here the symptom criteria belonging to the CPES dataset in the same manner 
individual PHQ-9 items were analyzed in Study II. These analyses are not published elsewhere, and were 
conducted for complementing the information in this doctoral dissertation summary. The WHO-CIDI
included more detailed information on symptoms, that we merged together to correspond to the 
compound criteria in DSM-IV and therefore to be comparable to other measurements (e.g. feelings of 
worthlessness and guilt were two different items, which we merged into one). The binary outcomes were 
high interference with life and being often unable to carry out daily activities. The logistic regression 
models for impairment are shown in Table 5. The models were adjusted for age, sex, marital status,
ethnicity, and number of chronic conditions. The 56% of respondents reported that, while suffering their 
most severe depressive episode, their symptoms interfered “a lot” or “extremely” with their lives. Of 
those who reported some degree of interference, the 29% stated that they had been “often unable” to
carry out daily activities due to that depressive episode. Such high rate of self-reported impairment stems 
from the fact that the interview refers to the worst affective episode the respondents remember.
The symptom-level associations in Table 5 are rather consistent between the two outcomes. 
Depressed mood, difficulties to concentrate or indecisiveness, and thoughts of death or self-harm showed 
significant associations with high interference with life, which were otherwise not statistically significant 
with regard to being often unable to carry out daily activities. The association with depressed mood was 
particularly large (OR=18.1). The symptoms bearing similar associations with both outcomes were 
anhedonia, appetite and weight changes, and self-criticism. Nagelkerke’s R2 was .106 for the interference 
model, and .105 for the inability model. The multi-stage probability weights were used for computing 
these models.
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Table 5. Binary logistic regression estimates for symptom criteria of Major Depression, predicting two 
indicators of impairment in CPES (n= 4 152).
Symptom criteria
of MDE (yes/no)
Outcome: a lot or extreme 
interference with lifea
Outcome: often unable to carry out 
daily activities due to symptomsa
OR SE Z p-value OR SE Z p-value
Depressed mood 18.102 .752 3.850 <.001** 1.000 1.025 .000 1.000
Anhedonia 3.184 .313 3.702 <.001** 5.877 .605 2.928 .003**
Appetite or weight
changes 
2.192 .309 2.543 .011* 2.455 .405 2.216 .027*
Sleep problems 1.946 .372 1.793 .073 2.487 .598 1.523 .128
Psychomotor 
disturbances
1.505 .309 1.325 .185 1.578 .259 1.759 .079
Fatigue .905 .377 -.265 .791 .973 .373 -.071 .943
Self-criticism 2.489 .402 2.270 .023* 2.675 .491 2.005 .045*
Difficulties to 
concentrate
2.330 .373 2.266 .023* 2.625 .554 1.740 .082
Thoughts of death 
or self-harm
2.627 .261 3.707 .001** 1.201 .247 .738 .461
Footnote. Models adjusted for age, gender, ethnicity, marital status, and number of chronic conditions.
Estimates are sample-weighted. aThe symptoms reported concern the “worst” affective episode the 
respondent remembers. *: statistically significant at α=.05. **: statistically significant at α=.01. OR: Odds 
ratio, SE: standard error of the estimate.
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The role of gender and age group in the association between symptom criteria of MD and self-reported 
functional impairment.
Aggregated sum-scores
Gender did not play a role in the association between severe self-reported impairment and the depressive 
symptoms causing it, according to the regression models in Study II (i.e. p-value >.05 in all models).
Age in years predicted severe functional impairment, both as a main effect (additive; b = .02, Z = 3.04, p-
value = .002) and moderating the association between PHQ-9 sum-score and very or extreme impairment 
(non-additive; b = -.001, Z = -2.60, p-value = .009). We further inspected this moderating effect by 
categorizing age into four age groups. The main and interaction terms remained statistically significant. 
The predicted values differed when comparing the oldest group (those aged 66 or above) to the two 
youngest groups (18 to 30 and 31 to 50). The associations can be seen in Figure 3, where the model 
predictions are displayed against age group. The model was adjusted for gender, number of co-occurring 
medical diseases, marital status, living below the poverty threshold, and NHANES cohort year.
According to the model, being depression sum-scores mild (ranging from 1 to 9), older adults 
were slightly more likely to report severe impairment than were younger adults. However, as depression 
scores increased from moderate onward, participants aged 66 and older were increasingly less likely than 
middle-aged adults to report severe impairment. For example, at a score of 20 the probability of feeling 
severely impaired was 53% in the age group over 65, and 67% in the age group of 31 to 50 year-olds.
Individual symptoms
Gender did not play a role in the association between self-reported impairment and individual symptoms 
causing it. Age group did have a moderating effect on the association between individual depressive 
criteria and severe functional impairment. Three of the nine symptoms showed a significant interaction 
term with age group. These symptoms were depressed mood, concentration difficulties, and self-
criticism. The interaction effects are displayed in Figure 4 indicating that individuals aged 31 to 65 were 
more likely to report that carrying out normal activities was very or extremely difficult when suffering 
from these symptoms.  
Post-hoc analyses revealed that these three symptoms showing interaction with age group 
explained the interaction effect seen at the aggregate level: once removed the three items from the sum-
score, the moderating effect of age on sum-score was not statistically significant.   
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Figure 3. Logistic model fitted probabilities for experiencing as very or extremely difficult to carry out 
daily activities as predicted by PHQ-9 scores in NHANES (2005-2015, n= 34 963). 
Footnote. The 95% confidence intervals are presented as a grey area around the lines. The annotations 
and dashed vertical lines correspond to previously established cut-off points for degree of depression in 
PHQ-9 scores.
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Figure 4. Fitted probabilities for experiencing as very or extremely difficult to carry out daily activities,
as predicted by the PHQ-9 symptoms which showed moderating effect by age group in NHANES 
(2005-2015, n= 34 963).
Footnote. The whiskers correspond to the 95% confidence intervals.
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Direction of dependence among specific symptoms of depression.
Confirmatory tetrad analyses invariably rejected the unidimensional model, for each of the six NHANES 
samples. Consequently, we conducted direction of dependence analyses. Due to the novelty of this 
technique in psychopathology, we applied the algorithm separately to the six samples (NHANES year 
cohorts 2005-2006 to 2015-2016). This way, the replicability of the results of this exploratory method 
was shown. The algorithm DirectLiNGAM estimated a virtually identic dependence ordering for each of 
the six samples (Figure 5).
We estimated sampling-weighted, conditional probabilities for pairs of symptoms in the overall 
NHANES sample (Table 6). This descriptive information does not imply direction of dependence, but 
may assist in better characterizing which symptoms tend to be present when others occur. The tables are 
interpreted as the percentage of the population reporting a symptoms given that another symptom is 
present (e.g. for those endorsing low mood, what proportion reported anhedonia). Thus, the rates only 
imply bivariate associations, which means they are not adjusted for the presence of other relevant 
symptoms or variables that may explain the bivariate relationship. The conditional probabilities are lower 
than those reported by Zimmerman et al. (2006a) on otherwise similar analyses conducted on a clinical 
sample of outpatients, which seems a reasonable difference of general population as compared to clinical 
samples. The information contained in Table 6 has not been previously published in any original 
publication of this dissertation.
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Figure 5. Directed Acyclic Graph displaying the direction of dependence estimated by DirectLiNGAM
separately in six cross-sectional NHANES cohorts (2005-2015).
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Table 6. Conditional probabilities between pairs of depressive symptoms as assessed by PHQ-9.
NHANES samples 2005-2015.
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Anhedonia - 55a 25 27 34 47 41 42 55 53
Depressed mood 48a - 24 26 31 58 43 43 76 55
Sleep problems 54 59 - 52 53 60 59 59 66 63
Fatigue 60 65 55 - 60 64 63 61 70 72
Appetite or weight
changes 
40 42 29 32 - 47 44 46 52 48
Self-criticism 33 46 20 20 28 - 38 38 71 46
Difficulties to 
concentrate or 
indecisiveness
32 37 21 22 29 42 - 49 54 46
Psychomotor 
disturbances
19 22 13 12 18 25 29 - 36 31
Thoughts of death 
or self-harm
7 12 4 4 6 14 9 11 - 14
Severe impairment 22 27 13 14 17 28 25 29 44 -
Note. a The table should be read as follows: 48% of patients with anhedonia reported depressed 
mood, whereas 55% of patients with depressed mood were anhedonic.
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Discussion
This thesis examined the association of depressive symptoms and self-rated functional impairment in 
population-based samples of adults from the United States. Knowing more precisely how individual 
symptoms relate to relevant outcomes is valuable for disentangling the heterogeneity of depression. We 
will next briefly list the main findings of this dissertation study-wise. In the following sections, we will 
discuss the implications of these findings while bearing in mind the five aims of the dissertation, and 
interpret them in the context of other literature.
In Study I, we inspected whether the psychometric severity of diagnostic symptoms was useful 
as a parallel diagnostic feature. If so, this information could help clinicians working within the DSM 
framework. In three of the four disorders we examined, psychometric severity offered additional 
information over and above symptom counts. Results of the CPES data showed a dose-response 
relationship of psychometric severity with psychosocial disability for GAD, Mania, and PTSD, with the 
exception of MD. The latent variable model of MDE showed some suboptimal characteristics. Possible 
reasons are misspecification, and that the items were not suitable indicators of a common latent trait (i.e. 
depression). Thus, it did not appear as an adequate model to continue with in future analyses, and we 
consequently departed from modeling observed variables in later studies. 
In Study II, we compared sum-scores and individual symptoms as predictors of severe functional 
impairment using NHANES data. The goodness of fit of these models suggested that modeling 
depression with individual symptoms marginally improved the predictive power of the model, as 
compared to modeling with the sum-score. In Study II, we also studied whether gender and age groups 
have implications for the impairment associated with MD symptom criteria. We found no evidence of 
the role of gender, and found that age group showed a moderating role for three symptoms: depressed 
mood, concentration difficulties, and self-criticism. Adults aged 31 to 65 were particularly prone to 
reporting severe functional impairment when suffering from these symptoms, as compared to younger 
and older adults. Other symptoms had a constant association with severe functional impairment across 
age groups, with the exception of sleep problems, appetite changes, and thoughts of self-harm and death, 
which did not hold any significant association with self-reported severe impairment in the mutually
adjusted model.
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In Study III, we assessed more exhaustively the suitability of a latent trait model to the four 
symptom criteria specific of MD (i.e. depressed mood, anhedonia, self-criticism, and thoughts of death 
or self-harm), by means of bootstrapped confirmatory tetrad test on the NHANES data. These four 
symptoms were selected because they seem to constitute a tighter symptom cluster, from which somatic 
symptoms differ consistently. Our analyses, based on six replications upon the large population-based 
cohorts, indicated unanimously that the unidimensional latent model does not fit the observed data. The 
six cohorts were then analyzed with the DirectLiNGAM algorithm, that aims to infer direction of 
dependence in non-Gaussian and cross-sectional data, based on their statistical distribution. The six 
replications indicated widely the same directed network: thoughts of death and self-harm Æ self-criticism 
Æ depressed mood Æ anhedonia. We discussed that the direction of dependence methods (among which 
LiNGAM is) are an untapped resource for psychiatric epidemiology because of exploding information 
commonly found in the field: non-Gaussian, cross-sectional data, from correlational studies. However, 
the performance of DirectLiNGAM with ordinal and noisy data remains underexplored. We therefore 
performed brief simulation studies assessing its estimation success under multiple conditions. The study
revealed that DirectLiNGAM is a rather robust method for estimating direction of dependence in those 
circumstances, particularly with large samples and variables with the same number of categories.
Sum-scores as indicators of depressive symptoms
As mentioned above, we found that modeling depression with individual symptoms marginally improved 
the predictive power of the model. However, there is no standard rule for evaluating whether a change 
of 1.5% is indeed a significant improvement on model prediction, as compared to sum-scores.
Nagelkerke’s R2 does not penalize for model complexity, and thus the value of such improvement in 
exchange to eight additional variables is, at least, questionable. Thus, from the statistical viewpoint we 
may conclude that sum-scores functioned about as efficiently as individual symptoms in predicting 
subjective severe functional impairment.
There are additional considerations from the substantive viewpoint. Examining individual 
symptoms offered in our study a deeper understanding of depression as a syndrome. For example, we 
found in post-hoc analyses that it was three symptoms that drove the interaction effect observed between 
the depression sum-scores and age on functional impairment. This information was concealed within a
single value in the aggregate sum-score. If our finding held across studies, this would imply that adults 
from middle age to retirement are more prone to considering themselves as severely impaired by those 
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three depressive symptoms, in comparison with younger and older adults. However, it is also possible 
that the symptoms causing higher burden to younger adults and those at retirement age are not well 
captured within the standard MD symptom criteria. Notwithstanding, this finding was only revealed 
when analyzing and the level of individual symptoms. By analyzing aggregates, we take the risk of 
missing useful insights.
A second important caveat of using symptom aggregates, worth considering here, is lack of 
content overlap across scales. This was minimized in the studies of this dissertation by restricting the 
symptoms analyzed to the current DSM symptom criteria. However, plenty of studies based their results 
on depression scales, which scope and content may vary considerably. Reporting and analyzing mere 
sum-scores comes with the pitfall of ignoring whether it is the accumulation of symptoms that 
explains an association (for which sum-scores are suitable), or is it particular symptoms which drive 
the effect observed (as we saw in Study II). A combination of both is naturally possible. Information 
about these important etiological mechanisms are made accessible by comparing systematically 
individual symptoms and their aggregates. 
Individual depressive symptoms and self-rated functional impairment
All symptoms were, to more or less extent positively related to impairment. This is presumable and has 
indeed little novelty as a research finding (e.g. Kendler & Gardner, 1998). The novelty was examining,
in naturalistic samples, the association of individual symptoms on self-rated functional impairment while 
adjusting for all others. All symptoms are associated with impairment when examined one by one, but 
which of them are informative when taking all simultaneously into account is different. A regression 
estimate which is not statistically significant in a mutually-adjusted model tells that the variable (i.e. 
symptom) does not contribute to the predictive ability of the model over and above the rest of the 
variables included. In this sense, our approach is different to the more common study of depressive 
symptoms as aggregates. For a disorder being as heterogeneous as MD, a symptom-based approach 
has the potential to reveal systematic associations of concrete symptoms that emerge while 
controlling for the presence of all others. If these results were stable and replicated across different 
studies, specific symptoms could offer useful information in the presence of a variety of symptom 
presentations. Those symptoms that relate to etiological or prognostic factors independently have 
obvious implications for treatment planning, especially if they bear an influence on other symptoms 
too.
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We found no clear trend between symptom prevalence and association with functional 
impairment. Put differently, both very prevalent and relatively infrequent symptoms showed associations 
with functional impairment. For example, depressed mood and anhedonia are core symptoms and tend 
to be endorsed easily, relative to other symptoms. Both emerged as significant predictors of functional 
impairment systematically in our analyses. However, sleep problems were practically as frequent in our 
data, yet the association of this symptom was never statistically significant after adjusting for the other 
criteria. Thus, a consistent finding was that functional impairment was not simply approximated from 
prevalence distributions of symptoms (e.g. very prevalent symptom expectedly more or less disabling 
than an infrequent symptom). This could explain, at least to some extent, the poorly informative estimates 
of psychometric severity in Study I. The severity parameter of IRT models is linked to prevalence rates, 
the more often the item is endorsed (i.e. here symptom), the lower the severity estimate (de Ayala, 2013).
The statistically non-significant regression weight could be explained by the (prevalence-based) 
estimated severity not having a linear relationship with the outcome variable, WHODAS.
The regression models revealed two other insights. First, our models showed a rather low 
predictive power upon severe self-rated impairment, as measured by Nagelkerke’s pseudo-R2. This 
suggests that functional impairment attributed to depressive symptoms was not a simple function 
of the symptoms or their counts. Other previous studies of clinical MD have similarly argued that 
symptoms and functional impairment are rather different components of severity, not directly 
approximated by another (Lux et al., 2010; Zimmerman et al., 2008, 2012, 2018). Thus, measuring the 
functional impact of depression seems necessary for assessing the overall severity of the syndrome also 
in research. 
A second finding related to the predictive power of the models is that the unique contribution of 
depressive symptoms was rather small and of similar size across symptoms, suggesting that the 
association of individual depressive symptoms with impairment was ambiguous or overlapping.
These results are in line with those of a recent study by de Vries and colleagues (2018). They compared 
similarly sum-scores and individual symptoms in predicting response to antidepressants (monitored at 
second week, outcome registered on the sixth week), and concluded that individual symptoms did not 
add meaningful predictive information to the sum-score. They hypothesized the reason was that 
prediction of treatment response was not particularly symptom-specific (i.e. a wide range of symptoms 
involved, mixed in domain). However, clinical studies have also shown stronger symptom-specific 
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findings. For instance, Fried and Nesse (2014) calculated the relative importance of individual predictors 
over WHODAS scores and found that symptoms drastically varied on their effects on impairment. Their 
measure was based on average stepwise changes on a linear model, and estimated over unadjusted R2.
This disagreement could stem from differences in the measurement of symptom-specific contributions 
to the models, or from real differences in the association between symptoms and functional impairment 
across community-based and clinical samples. 
The two core criteria of depression, depressed mood and anhedonia, are symptoms most 
commonly found to predict impairment, in our research and in others’ (Faravelli et al., 1996; Fried & 
Nesse, 2014; Tweed, 1993). It is well known that depressed mood is among the most, if not the most 
common depressive symptom. Depressed mood is invariably present in clinical cases of varying severity, 
and also prevalent in subthreshold and dysphoric episodes which may transient on their own (Horwitz & 
Wakefield, 2007; Zimmerman, McGlinchey, Young, & Chelminski, 2006). Anhedonia and motivational 
symptomatology may be similarly described as rather prevalent and characteristic of clinical and less 
severe states (Rosenström & Jokela, 2017; Zimmerman, Chelminski, McGlinchey, & Young, 2006; 
Zimmerman, McGlinchey, Young, & Chelminski, 2006b). The symptoms of depressed mood, followed 
by anhedonia, were dependent on death thoughts and self-criticism according to the DirectLiNGAM-
based results. Depressed mood and anhedonia were similarly likely to react to changes in other symptoms
in a longitudinal study by Bringmann and colleagues (2015) on a clinical sample. They stated that sadness 
and loss of interest “do not play a large role in funneling the symptom spread themselves” (Bringmann 
et al., 2015, p. 7). In the same direction, a recent study by Boschloo and colleagues found that an internet-
based intervention decreased depressed mood and anhedonia through the improvement of other 
symptoms, among which was self-criticism (Boschloo et al., 2019).
However, there is an additional interpretation of the LiNGAM-based network, which is estimated 
based on distributional properties. It has to do with sensitivity and specificity of the symptoms. Being 
depressed mood and anhedonia rather prevalent (and possibly reactive to other symptoms), they generally 
show high sensitivity and rather low specificity. Thereby, most of the severely impaired individuals 
suffer from depressed mood and anhedonia, but these symptoms themselves discriminate poorly between 
cases with more or less severe depression. This is because they tend to be present when others are, but 
the opposite may not hold (see Table 6). The Direct-LiNGAM algorithm uses a kernel estimate of mutual 
information, and so the direction of dependence estimated has to do with the informative of a variable 
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about another. This high sensitivity has to do as well with the fact that the two core symptoms registered 
consistently an association with severe functional impairment. 
Across different analyses, there was systematic evidence that feelings of worthlessness and guilt
played a role in severe functional impairment, and are closely related to other symptoms too. Self-
criticism showed a significant association with all the indicators of severe functional impairment we 
tested in the regression models. Similarly, Faravelli at colleagues (1996) found that hopelessness and 
guilt were among the most correlated with the severity and global functioning scores. Moreover, in Study 
II self-criticism showed an age-related pattern, according to which adults aged 31 to 65 were more prone 
to report severe functional impairment than adults of other ages. This complements previous literature 
pointing at the informative value of this symptom. For example, a study analyzing symptom presentation 
and MD onset found that two symptoms predict onset before age of 60: feelings of worthlessness and 
guilt, and depressed mood (Heun, Kockler, & Papassotiropoulos, 2000). A recent follow-up study 
examining the stability of cognitive vulnerability and depressive symptoms found both are more stable 
than expected, indicating that affective symptoms tend to be maintained hand in hand with trait-like 
constructs, such as hopelessness, rumination, and worry (Struijs et al., 2020). Another study showed that 
subjects who had experienced earlier onset depression were more likely, after the age of 65, to report 
feelings of worthlessness and guilt than those with no previous depression (Gallagher et al., 2009). These 
findings suggest that self-criticism may reach clinical implications that are consistent with the association
on severe impairment we found across adulthood. Furthermore, feelings of worthlessness and suicidal 
thoughts are considered criteria for complicated depression (Wakefield, Schmitz, First, & Horwitz, 
2007), which is empirically related to a number of clinically relevant outcomes. Feelings of worthlessness
also predicts concurrent and post-remission suicide attempts (Bolton et al., 2008; McGirr et al., 2007; 
Wakefield & Schmitz, 2015).
In the directed network, self-criticism was the second most dominating symptom after thoughts 
of death and self-harm. In the longitudinal study by Bringmann et al. (2015), feelings of worthlessness 
and guilt were among the most influential over other symptoms, while being very central to the network.
In their study, suicidality was the symptom influencing others the most, while being the least influenced 
by the others. This is another similarity with our directed network, in which thoughts of death and self-
harm were a dependence indicator for the other cognitive-affective symptoms. Dependence here 
implies that it more reliably and linearly implies the presence of other symptoms. This can stem from a 
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direct association, or from other etiological factors which underlie the directed chain observed –this 
would be a violation to the assumptions of the model, but a possibility.
A prospective study on suicidal acts during adolescence found that cognitive symptoms 
dominated the profile of suicide attempters, indicating the simultaneous activation of all these symptoms 
around suicidal acts (Nrugham, Larsson, & Sund, 2008). Other studies of temporal antecedence,
understood as an indication of causal mechanisms, have pointed at these symptom dynamics via 
variability across time. In these studies, suicidality is the most stable symptom, while depressed mood 
and anhedonia tend to vary the most. Apart from the aforementioned study by Bringmann et al. (2015), 
other follow-up studies followed patients for a time-span of two to nine years (Karp et al., 2004; Oquendo 
et al., 2004; van Eeden, van Hemert, Carlier, Penninx, & Giltay, in press). Despite of the stability of 
suicidal thoughts in longer time intervals, there is some recent evidence of large variability across short 
timespans, like the course of one day (Kleiman et al., 2017). The authors found that other symptoms 
identified as risk factors for suicidality, like hopelessness, loneliness, and burdensomeness, were limited 
in predicting suicidal thoughts. These symptoms did also show high fluctuation. These intricate findings 
based on repeated measures illustrate how challenging it is to measure accurately the temporal dynamics 
of depressive symptoms. Note that these works are all based on clinical samples, to our knowledge no 
longitudinal study has yet addressed depressive symptom variability in the general population. 
Overall, a question to further clarify is whether suicidality is simply more stable over long 
periods of time, or has an additional role in reinforcing the other symptoms, as DirectLiNGAM
suggested. Kleiman et al. (2018) reached a similar point in an ecological momentary assessment study, 
in which participants who had recently attempted suicide experienced downward shifts in negative 
emotion after reporting suicidal thoughts. The authors hypothesize that suicidal thoughts may be 
reinforcing, and thereby tend to become more persistent. Experimental studies on cognitive reappraisal, 
a technique for cognitive reframing of emotional cues, have conversely found that applying reappraisal 
reduces self-reported negative emotions and the activity of the amygdala, a key element in emotional 
processing in the brain (McRae, 2016). The evidence on cognitive reappraisal is ample for healthy and 
depressed participants alike. In particular, some recent empirical evidence points at the protective effect 
of cognitive reappraisal against suicidal behavior (Forkmann et al., 2014; Kudinova et al., 2016; Ong & 
Thompson, 2019; Richmond, Hasking, & Meaney, 2017).
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The somatic symptoms we analyzed shed mixed results. Very prevalent symptoms, like 
difficulties with sleep and fatigue, showed mostly no independent associations with severe self-reported 
impairment. Appetite and weight changes registered somewhat inconsistent pattern across datasets and 
analyses. Concentration difficulties emerged as the most strongly related to functional impairment 
through different analyses, and showed an additional interaction effect with age group in Study II. The 
impairing effects of concentration difficulties are well documented in studies of clinical depression for
its link to cognitive impairment. A recent review examining the clinical relationship between cognitive 
impairment and psychosocial functioning in patients of MDD highlighted that “cognitive deficits are 
associated with short-term and longitudinal functional deficits“, and that “older age and greater illness 
severity appear to increase susceptibility to and magnitude of psychosocial deficits in MDD” 
(Cambridge, Knight, Mills, & Baune, 2018, p. 170).
It is possible that the associations of somatic symptoms with functioning vary across particular
clinical samples. Differences over the severity continuum of depression could help to disentangle the 
mixed results found for psychosomatic symptoms (Thombs et al., 2010), which undoubtedly belong to 
affective disorders (Simon, VonKorff, Piccinelli, Fullerton, & Ormel, 1999). The inconclusive pattern
could also stem from the intrinsic challenge of research in psychosomatic symptoms. Somatic symptoms 
tend to be frequent in the general population, and stem from multiple causes including physical and 
mental illness. The use of population-based data may bring about very noisy measures of somatic 
symptoms, which in turn results in mixed findings. Such thing does also imply that somatic symptoms 
are challenging as diagnostic criteria as well, and motivate investing resources for studying their validity 
and how to measure them more accurately in the context of affective disorders.
Contributions of our work within current mental health
The traditional unidimensional model, based on a latent variable, failed to accommodate the data in the 
two datasets we utilized. At the same time, we found evidence of symptoms relating differently to
subjective functional impairment. Our findings are in the same line with other literature that quite 
consistently finds arguments against the current “one size fits all” approach. This is a concern from the 
perspective of validity of the operational definition of MD. First, symptom presentation patterns; and 
second, their specific covariation with clinical validators, are basic for further advancing psychiatric 
disorders, and particularly for the challenges of MD as a diagnostic entity.
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The fundamental argument for bottom-up approaches in research is the clarity of handling 
individual symptoms, as compared to handling depression scores. Depression aggregates may be 
insightful, but could hide important information more accessible with symptom-level approaches. This 
would ease reporting, comparing, and reviewing findings (Costello, 1993). Second, the use of clinically 
relevant criteria is important in mental health because most psychiatric disorders do not have natural 
boundaries nor stablished etiopathogenesis. A “good” symptom is not defined by biomarkers, but it is to 
prove being useful based on criteria defined by experts, such as informativeness and discrimination of 
psychopathological states. This knowledge on symptoms would bring useful output for psychopathology 
at no cost, with potential for theoretical and clinical developments. We consider three wide domains in 
which the approaches we have presented have a potential contribution.
The first one is the evaluation and refinement of current diagnostic systems. The diagnostic 
definition of MD, as most of the psychiatric diagnoses is not evidence-based, but the result of consensus 
among experts, tradition, and historical conjunctures (e.g. Kendler, 2016; Maj, 2012). The current
diagnostic definition of depression has changed very little since the Feighner criteria were published in 
1972 (Feighner et al., 1972). The Feighner criteria were the basis for developing the Research Diagnostic 
Criteria, which were in turn central to DSM-III. Thus, the Feighner criteria had a tremendous influence 
on the systematization of mental illness, an influence that remains alive today. A main goal that the 
authors of the Feighner criteria had in common was their concern about validity and the evidential support 
of psychiatric diagnosis (Kendler, Muñoz, & Murphy, 2010). Their motivation was promoting systematic 
and empirically-oriented psychiatric diagnosis. In what comes to depression, they reportedly looked into 
epidemiological surveys and were particularly influenced by an empirical article authored by a group of 
psychiatrists interested in comparative clinical descriptions (Cassidy et al., 1957). To the best of our 
knowledge, the specific process was never documented (Kendler et al., 2010).
Despite generating abundant research, the criteria themselves have undergone little change. We 
have accumulated plenty of empirical knowledge and the needs of the field have changed, yet we hardly 
ever question the validity of these criteria. They are accepted on the fly and used as a cornerstone for 
research. If revisions were to happen, this would call for a robust symptom-based body of literature to 
inform any decisions. The revisions undertaken in DSM-5 for the Substance Use Disorder are a good 
example of this. The current category combines the old diagnoses of substance use and substance 
dependence. The symptom descriptions were strengthened, the symptom craving was added, and the 
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symptom legal problems was excluded. The modifications were largely based on symptom-level 
considerations and research, and in the pursue of improving the validity of the diagnostic definitions 
(Hasin et al., 2013). This means, in practice, the aim of making the diagnostic definitions more 
coherent with empirical data, external validators, and current symptomatic representations.
Changes of this magnitude have not yet taken place for MD. This is logical, because depression seems 
rather complex etiologically, as it is demonstrated by extensive literature with somewhat inconclusive 
findings and by our own research results (e.g. in Study I the concurrent validity of all other disorders was 
well approximated by severity estimates, and the IRT models functioned acceptably). Anyways, for the 
field to be prepared for any future changes, solid empirical evidence on the validity of individual 
diagnostic criteria would be required.
The second domain of potential application is clinical practice. It is not new for the field that 
clinical frameworks depart from a symptom-level basis. For instance, the cognitive theories of depression 
posit symptom-to-symptom mechanisms and stablish a workflow at the ground level: cognitive biases 
(through working memory, perception, reward processing, and thought) reinforce emotion dysregulation.
Because resources are limited and depression is very burdensome, those intervention programs that
minimize the impact of depression are particularly valuable to patients, to their families, and to society. 
This is why the role of external outcomes, like functional impairment, can be key in profiling the most 
influential symptom presentations. Clinical practices may become more evidence-based upon producing 
further empirical research on symptoms and their impact on functioning.
In contrast with the relevance of standardization for academics, it has been shown that 
professionals working in clinical psychology and psychiatry do not follow strictly standard guidelines, 
but mostly rely on their own experience when selecting a treatment (First et al., 2018). Kamenov at al. 
(2017) conducted a multi-informant study about treatment effectiveness in depression. They
implemented a literature review, an expert survey, and interviewed patients. According to their results,
current literature differs from clinicians in that, while research emphasizes the role of symptom 
aggregates (scores) in severity and recovery, clinicians highlight the importance of a variety of 
functioning domains and personal factors (e.g. self-concept, self-efficacy) in the treatment and recovery 
from depression. Moreover, patients and clinicians pointed at certain areas targeted by interventions that 
are not commonly addressed by the literature, like interpersonal relationships, problems in 
communication, or lack of social participation – areas among the most affected by depression according 
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to the authors (Kamenov et al., 2016). Kamenov and colleagues argued in favor of adapting research to 
clinical reality, because “a higher sum-score might mean a higher number of less affected functioning 
areas or a smaller number of domains with marked deterioration” (2017, p. 7).
The third domain is the development of etiological models and theories. Some examples of
bottom-up developments have already taken place, driven by current research programs as the HiTOP 
and network approaches (Borsboom, 2017; Kotov et al., 2018). The HiTOP (Hierarchical Taxonomy Of 
Psychopathology) argues that most of the problems with current diagnostic taxonomies happen because 
the disorder classifications do not match empirical reality. There is a high degree of comorbidity among 
certain disorders, besides a lack of specificity of risk factors and correlates. Both may be explained by 
the fact that current diagnostic categories can be mapped within wider spectra, spectra that explains their 
covariation through a dependence hierarchy. They consider that signs and symptoms are the starting 
building block, from which to continue towards higher levels in the hierarchy (e.g. internalizing and 
externalizing factors, which group multiple disorders). The idea, as Markon put it, is to develop “model 
frameworks ‘downward’ as well as ‘outward’, by analyzing symptoms rather than diagnoses, and by 
integrating symptoms from Axis I and II disorders in a common framework.” (2010, p. 273). On its 
behalf, the network approach to psychopathology has emphasized the role of direct symptom-to-
symptom dynamics in the onset and maintenance of psychopathology. The role of symptoms is principal 
in the theory, which is characterized by statistical models based on only observed variables (symptom), 
although latent variables in network models could be implemented as well. 
Another potential application is for etiological models that benefit from distribution-based casual 
inference. Distribution-based inferences point at the most likely direction of causation between pairs (or 
groups) of variables, under certain assumptions. These methods are a suitable addition to more general 
studies of triangulation in etiologic epidemiology (Lawlor, Tilling, & Smith, 2017). The principle 
behind triangulation is that an etiological model may be inferred for being robust across multiple methods
that rely in non-overlapping assumptions. Thus, we may derive direction of causation upon an inference 
that holds across estimators, which make different key assumptions and have differing limitations to suit 
the observed data. Several methods used for similar purposes may be used in combination (Rosenström 
& García-Velázquez, in press). Direction of causation models, from behavioral genetics, use family data, 
assume normally-distributed variables, and estimate additive genetic, shared and non-shared 
environmental influences to determine of A on B (Heath et al., 1993). LiNGAM-based algorithms, 
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differently, require non-Gaussian distributions and use higher moments to determine direction of 
dependence between A and B (Shimizu, 2018). Methods estimating direction of dependence are an
untapped resource for generating testable hypotheses and supporting insights from variety of methods in
current psychopathology.
Methodological considerations and future directions
Population-based, cross-sectional data
We used representative, cross-sectional samples of the adult population of the United States. The breadth 
of the studies allowed to take into account a number of relevant covariates for, such as number of physical 
diseases, and to compute nationally representative estimates. Studying the epidemiology of 
psychopathology is essential for better characterizing pathological symptom presentations, since the 
general population offers a reference of the natural distribution of psychopathology. Psychopathology is 
a matter of degree, and therefore mapping the whole continuum of severity is important for advancing 
the understanding of common disorders. Moreover, general population studies cover a wider spectrum 
of depressive symptomatology, from spare to severe symptom presentations, as compared to clinical
samples which comprise more developed forms of the syndrome. Thus, representativeness and size of 
the datasets are a strength of this dissertation work. At the same time, we identify a number of limitations 
in our data. 
First, both studies are limited to the adult population of the United States, and thus the 
interpretation of our findings is not warranted for other populations. It is well known that depressive 
symptoms present differently across cultures (De Vaus, Hornsey, Kuppens, & Bastian, 2018; Ryder et 
al., 2008). Most research in mental health focuses on high-income countries, although the burden of 
depression and suicide are as high or higher in low- and middle-income areas (Guzmán, Cha, Ribeiro, & 
Franklin, 2019; Liu et al., 2019; WHO, 2017). Additionally, community samples may have different 
symptom presentation than clinical samples in terms of prevalence and structure as well (Foster & 
Mohler-Kuo, 2018). This entails that our results are derived from those at risk (in the case of CPES data) 
or for the general population (NHANES), and may not hold in strictly clinical populations, for which it 
would be necessary to carry out specific research. There were, however, some similarities between our 
findings and those based on clinical samples presented by Faravelli et al. (1996), Fried and Nesse (2014),
and Tweed (1993). In terms of representativeness, it would be convenient to systematically compare 
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structural estimates and patterns of symptom associations with impairment across different samples as 
populations.
Another common feature in both studies is cross-sectional design. Cross-sectional data allows 
between-individual comparisons, but not to examine intra-individual symptom patterns across time, nor
symptom changes. With respect to the implications of time, longitudinal studies and a wider time-span 
are needed to ascertain whether the patterns observed in Study II were actually age-dependent, and to 
disentangle possible cohort effects. Moreover, longitudinal data may support to some extent causal 
inference and would have conveniently complemented the analyses we conducted, for example, in the 
case of LiNGAM analyses in Study III. Our interpretation of the direction of dependence dynamics could 
be tested in a longitudinal context, in which temporal antecedence together with dependence among 
symptoms with each other and with functional impairment can be studied in more detail. The use of 
cross-sectional data is incomplete when aiming to study comprehensively the heterogeneity of mental 
disorders, which takes place across individuals and symptoms, but also over time (de Vos, Wardenaar, 
Bos, Wit, & de Jonge, 2015; Wardenaar & de Jonge, 2013).
Measurement of depressive symptoms
It is worth to consider the characteristics of the instruments used in the CPES and NHANES 
studies for measuring depressive symptoms. First, there are a number of characteristics in particular that 
these measurements do not have in common, and which are worth to take into account when interpreting 
our results. 
The WHO-CIDI interview used in the CPES studies are based on a skip-question system. In the 
case of the depression module, the participant had to endorse having suffered an affective episode in 
order to administer the rest of the interview. Although most depressive episodes include mood symptoms 
or lack of interest (Zimmerman, McGlinchey, et al., 2006b), such filter-based design still forces a given 
dependence in the data and likely inflates the prevalence of the filter symptoms relative to the others.
Second, the items concern the most severe depressive episode, and not lifetime symptom endorsement 
patterns. This conveys three problems. First, the most severe episode or a person is not necessarily 
representative of their depressive syndrome, and makes difficult to extract generalizable information 
about depression. On the other hand, ratings of the worst episode are most informative of the impairment 
depression may exert to depressed, non-clinical individuals. In this sense the association between the 
episode and impairment would be captured better than queries about current symptoms. Second, it is 
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likely that a worst episode joins together more symptoms, and therefore symptoms’ joint (e.g. bivariate) 
occurrence patterns may be inflated too. Third, the worst episode could have happened decades ago or 
be still ongoing, which may have an influence in the reliability of recall. This aspect was not taken into 
account in our analyses. The responses to the interview were dichotomous, which in this case may 
decrease the noise of recall (i.e. it is easier to remember if something happened than its frequency or 
intensity). However, a drawback of dichotomous responses is the loss of information on the magnitude 
of symptom presentation, as compared with Likert-type response scales.
The PHQ-9 questionnaire (Kroenke & Spitzer, 2002) used in the NHANES study is a short form 
querying how often the participant had been suffering from depressive symptoms in the last two weeks.
In this case no skip-question systems apply, nor loss of information due to dichotomization or difficulties 
in recall. However, the PHQ-9 questionnaire is not specific for affective episodes. As such, a person 
suffering, for instance, from sleep problems for any other reason (e.g. physical health, caring of small 
children, or irregular work shifts) may endorse the symptom. Also psychomotor disturbances may be a 
result of thyroid dysfunction instead of depression. The scale does not stablish clearly that the queries 
relate to an affective episode. This implies that the occurrence of the symptoms is not strictly attributable 
to a dysphoric episode, and that the prevalence rates may be biased to some extent with respect to those 
strictly caused by depressive manifestations. PHQ-9 is suitable for approximating how frequent the 
symptoms are in an epidemiological sense, but not so much about how frequent depression may be in the 
population – needless to state that diagnosing depression requires a thorough evaluation entailing much 
more information than meeting the thresholds of duration and symptom amount. Another important 
limitation of this questionnaire is using compound measures of symptoms. When querying about lack of 
sleep and oversleep at the same time, it is impossible to discriminate differential prevalence or patterns 
with associations with other symptoms or outcomes. These compound symptoms may be similar (e.g. 
worthlessness and guilt) or just opposite (e.g. increase and decrease in weight), but studying them 
separately and examining their validity as symptoms is not possible in these cases (Fried, 2015, 2017b).
The aforementioned dissimilarities across the depression instruments may contribute to some of 
the differences found in symptom-impairment associations. At the same time, the results are not directly 
comparable between them because of the different nuances of the instruments (i.e. worst episode against 
epidemiological screening of symptoms). There is one characteristic that both measures, the WHO-CIDI 
and PHQ-9, have in common. The skip mechanism in the WHO-CIDI limits the amount of symptoms 
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evaluated other than those of DSM-IV (i.e. in order to assess the ICD diagnostic symptoms, the
respondent has to previously endorse a number and type of DSM-IV diagnostic symptoms). As to the 
PHQ-9, its content strictly corresponds to the DSM-IV criteria for MDE in a compound manner (i.e. two-
week period). It is a strength of this thesis dissertation that the results conform to the DSM-IV symptom 
criteria, an internationally accepted taxonomy. It is unarguable that the replicability of our results, and 
their interpretation into the context of previous literature is facilitated because of studying the stablished 
diagnostic symptoms of MD.
Despite of its numerous benefits, the practice of translating mental disorders into operational 
terms sometimes involves an oversimplification of psychopathology (Maj, 1998; Parnas & Bovet, 2014).
The extensive use of these operational criteria implies the risk that, at some point, research and clinical 
practice are lured away from considering other forms of symptomatic presentation than the diagnostic 
criteria in diagnostic manuals. Some of the factors underlying the shift away from the phenomenological 
tradition are, for instance, that grant-making bodies, scientific journals, or organizers of scientific 
meetings demand the use of the DSM criteria. In some countries in more applied settings, the diagnostic 
criteria are understood as the standard of experts’ consensus, and therefore any other public institution, 
insurance company, or teaching syllabi tend to comply with them. Treatments and guidelines are 
developed using these criteria as cornerstone of what is a prototypic mental disorder (Hyman, 2010). It 
is more efficient, in sum, to use the official diagnostic criteria than anything else, which may be less cost-
effective or subject to debate. This trend has lead through the decades to what experts call reification of
mental disorders (Andreasen, 2007; Hyman, 2007, 2010; Kendler, 2016; Patten, 2015; van Loo & 
Romeijn, 2018). A drawback to the exclusive focus on symptom criteria is neglecting other symptoms 
which maybe be relevant for the disorder. Their implications for the onset, development, or prognosis of 
depression could remain poorly recognized, behind the emphasis on the standard diagnostic criteria.  
The third edition of the DSM brought an enormous improvement to the reliability crisis of 
psychopathology, through the systematization of diagnostic descriptions with operational definitions.
After some time, a far-reaching and unintended pitfall of this effective systematization is the tendency to 
conflate the DSM criteria with the disorders themselves (Andreasen, 2007). Not only the diagnostic 
criteria are assumed to be correct, but are assumed to constitute the disorder. According to Kendler, “we 
have confused an index of a thing with the thing itself” (2016, p. 777). On the contrary, depression has 
been traditionally described with a wealth of symptomatic manifestations, some of them still present in 
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scales (Fried, 2017a; Santor et al., 2006). In a thorough review of the phenomenology of depression 
across the last century, Kendler (2016) argued that a great amount of these symptoms did not become
diagnostic criteria for reasons such as being too subtle, not succinct, time-consuming to evaluate, or lack 
specificity. The phenomenology of depression is much richer than the DSM criteria, involving areas as 
volition, metabolism, detachment experiences, and a variety of physical symptoms not covered partially 
or entirely in the official diagnostic definitions.
Thus, it is both a limitation and a strength of this thesis dissertation to be restricted to the DSM 
symptomatic criteria. A natural progression of symptom approaches to psychopathology is to broaden 
the symptomatic presentations studied, and to examine the performance of the current symptom criteria 
as compared to other symptoms which are currently ignored by the diagnostic manuals. Current research 
programs, such as HiTOP and the network approach, do benefit from a bottom-up paradigm for 
advancing knowledge on topics like comorbidity and the structure of mental disorders.
Comorbidity and other psychological factors 
Comorbidity was taken into account only partially in this dissertation. It is common that depressive 
symptoms co-occur with other mental syndromes (Rush et al., 2005; van Loo, Schoevers, Kendler, de 
Jonge, & Romeijn, 2016). The symptoms reported in the studies may be due to, or aggravated by other 
mental syndromes. This was not controlled for in our analyses and brings potential risk of confounded 
findings. There is evidence of cross-diagnostic subtypes relating symptoms of anxiety and depression to 
disability (Wanders et al., 2016). The sub-types, found in a large Dutch cohort, include low severity 
classes with predominant cognitive (“worried”) and somatic symptomatology, and subclinical and 
clinical classes showing a mixture of anxious and depressed presentations. The cross-diagnostic sub-
types showed differential associations to clinical validators, including disability, psychiatric diagnoses, 
and physical health status.  
There are other psychological phenomena that may play an important role in the relationship 
between depressive symptomatology and self-rated functioning. For instance traits such as self-efficacy, 
resilience, or neuroticism may moderate the actual or perceived impact of depressive symptoms on 
functioning. These variables may be particularly important to study in epidemiological surveys of 
depression because of the large proportion of non-clinical presentations. The psychological risk factors 
may emerge more clearly in analyses comprising the wide severity continuum of depression.  
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Physical medical conditions were adjusted for, although they were in both studies self-reported.
Self-reported medical data may be less reliable than that extracted from registers. Further studies shall 
examine the role of comorbid symptomatology in the association between depressive symptoms and 
functioning.
Measurement of functional impairment
In this dissertation we used different measurements of functional impairment. This is a strength, since 
the use of several indicators reduces the impact of systematic measurement error, particularly in single 
item measurement. Yet the differences between the indicators may contribute to the differences found in 
symptom patterns. There are several methodological considerations worth to discuss. First, there were 
two generic measurements of inability to carry out normal life, the WHODAS scale and the number of 
days disabled in the last month. These indicators are not solely attributable to depression and thus are not 
reliable indicators of depressive symptoms’ association with functioning. The two variables are self-
reported, but a positive aspect is that the information they collect is rather straightforward to rate (i.e. 
they do not require much subjective judgement). Second, the studies also included indicators of 
functional depression which were depression-specific. These are more valid indicators in terms of 
interpretation of results, since they reduce by design confounding effects of comorbid disorders. This is 
particularly beneficial in community samples which are rather heterogeneous (i.e., general population 
samples may present important comorbidity with other disorders, which is reduced in clinical samples 
through exclusion criteria). However, these indicators share the limitation of being single items, and to 
some extent subjective to rate (e.g. participants may differ in what they consider high interference of 
symptoms). 
The measurement of functional impairment implies a number of conceptual considerations. First, 
functional impairment is challenging to define or measure for being a complex construct, with no gold 
standard in mental health. McKnight and Kashdan (2009) defined three different domains in which 
depression could affect functioning: social, occupational, and physical. The indicators we used here were 
mixed in terms of what domains they measure, and sometimes left the participant the choice of what to 
consider as impairment or interference. For example, the PHQ-9 item and the interference item in CPES 
were clear in referring simultaneously to the three domains defined by McKnight and Kashdan, while it 
remains unclear what response process the participant followed. For example, whether all the functioning 
domains had the same weight on the participants’ consideration, and whether the rating was based on 
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averaged perception of burden, or on the burden attributed to the most impaired domain. The item 
measuring the number of days “unable to work or carry out your normal activities” is very ambiguous 
regarding what normal activities are. Thus, the use of single items that collapse so complex information 
presents important methodological and conceptual challenges. 
Future studies would benefit from more clear content and wording of the items measuring 
different domains of functioning, especially since there is some evidence that different symptoms impact 
different domains of life (Fried & Nesse, 2014). There is no standard scale at hand for measuring 
functional impairment of MD out of the field of effectiveness of interventions. Experts argue against the 
reductionist approach of effectiveness studies, which mostly focus on the alleviation of symptoms 
(through scores) while neglecting other important areas of impact that are themselves relevant for the 
patients (Kamenov et al., 2017; Lam, Parikh, Michalak, Dewa, & Kennedy, 2015; Zimmerman et al., 
2012). The research gap seen in studies of intervention effectiveness is now well recognized, while there 
is a lack of studies addressing the impairment associated with MD symptoms in naturalistic settings. 
Another important consideration is the directionality of effects. It is logical to assume that 
symptoms cause burden, while it is simultaneously possible that pre-morbid impairment is a risk factor 
for developing a given syndrome. The study by Bos et al. (2018) concluded that it is pre-existing 
functioning which predicts future depressive episodes, instead of residual symptoms that cause
impairment by lingering. Naturally, subclinical symptoms may cause such impairment in the first place.
The relationship between symptoms and impairment is rather complex, and thus we shall limit our 
interpretations to associations instead of causal directions. 
A third aspect to bear in mind are the consequences of reification for the measurement of 
functioning. Current impairment associated with depressive symptoms may be due to unreported 
symptoms, apart from those modeled here. These missing symptoms contribute to model error and may 
cause misspecification (Tweed, 1993). Related to measurement is also the response bias resulting from 
the tendency towards negativity of currently depressed individuals, which has been argued to affect rating 
of symptom and functioning (Morgado, Smith, Lecrubier, & Widlöcher, 1991).
There is no consensus or standard on what is impairment as caused by psychiatric disorders in a 
general sense, neither how to operationalize it. Experts have argued in the last years about its practical 
consequences and stated the need for a clearer conceptualization. For example, Mario Maj (2012, p. 535)
stated with respect to the current diagnostic systems, that “an attempt to operationalize in more objective 
84
terms the impairment criterion appears timely, since that criterion, in its current formulation, depends too 
much on the clinician’s and the patient’s subjective judgement and is so generic to be actually redundant”.
Conclusions and practical implications 
There are some overarching findings of this doctoral dissertation, which are worth to highlight. 
Our results align with other empirical studies indicating that functional impairment is a core component 
of disorder severity, not accurately approximated merely by symptoms (Lux et al., 2010; Zimmerman, 
Balling, Chelminski, & Dalrymple, 2018; Zimmerman, Morgan, et al., 2018). Moreover, a symptom 
being more or less prevalent did not imply correlate of more or less severe functional impairment. It 
became apparent that the common practice of using sum-scores has the benefit of approximating 
relatively well individual symptoms, while helpful insights may be obscured about how concrete 
symptoms relate to self-rated impairment. This is a critical disadvantage to aggregate-based approaches, 
especially in what comes to advancement of etiological aspects of the disorder.
Knowledge at the symptom level seems conceptually more useful for understanding of depression 
than aggregates. For instance, symptom-level analyses revealed that age group moderated the 
associations of three symptoms with self-rated impairment. This information was concealed behind the 
sum-score. If our findings replicate across studies, this would imply that middle-aged adults are more 
prone to consider certain symptoms as severely impairing, as compared to adults aged 30 and below and 
in retirement age. These symptoms are depressed mood, self-criticism, and impaired concentration.
Being resources limited, a practical implication of this is that prevention plans shall consider middle-
aged adults are particularly vulnerable to certain depressive symptoms, as compared to other age groups.
The associations of cognitive-affective symptoms among themselves and with functional 
impairment emerged distinctively. However, most associations between depressive symptoms and severe 
functional impairment turned out mostly unspecific, and therefore the clinical relevance of individual 
symptoms upon functioning calls for further exploration. There is compelling empirical evidence that 
functioning is a relevant factor for both the onset and remission of depressive disorder (Bos et al., 2018; 
McKnight & Kashdan, 2009). If our results hold across studies, a concrete output of this doctoral 
dissertation is that cognitive symptoms reinforce affective-motivational ones, which is a vulnerability
pathway for its consistent associations with severe functional impairment. A practical implication is that 
supporting individuals’ self-worth may protect against the development of depressive symptomatology 
and its corresponding impact on functioning.
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The studies in this doctoral dissertation shed light on the complex links between symptoms and 
functional impairment. Yet, the convoluted etiology of MD prevailed across analyses. Many aspects 
remained for further exploration and replication, such as the moderating effect of age, the dependence 
associations between cognitive-affective symptoms, or the inconsistent link of some symptoms with 
severe impairment. An important source of information, such as within-subject dynamics, was not 
explored. Our findings motivate considering a wider range of symptoms, both in terms of presentation
(e.g., from mild to severe and longitudinally) and content, for further understanding the heterogeneity of
depression. Similarly, functional impairment as a core component of severity calls for systematic
exploration, and for a more refined measurement (Lam, Filteau, & Milev, 2011; McKnight & Kashdan, 
2009; Zimmerman et al., 2008). The use of multi-item scales and instruments validated specifically for 
use in depression come as useful tools in the endeavor of better describing depression and its outcomes.
A more fine-grained analysis is undoubtedly beneficial in a clinical context (i.e. efficacy of 
treatment and remission), but also in epidemiological studies. It is necessary to reach systematic 
knowledge on the natural distributions of depressive symptoms and their links to clinically relevant
correlates. A better characterization of the severity of depression as a continuum is fundamental for 
theoretical developments in psychopathology, and potentially useful for planning more efficient 
interventions targeting the most disabling, dominant symptoms.
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